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Enclosed, please, find an electronic submission of a review manuscript entitled  
Advances in analytical tools and current statistical methods used in ultra-high-performance 
liquid chromatography-mass spectrometry of glycero-, glycerophospho- and sphingolipids 
written by Henri Avela and Heli Sirén for publication in International Journal of Mass 
Spectrometry. 
We have broadly reviewed the status of current RPLC-MS analytics in the light of UHPLC-MS 
studies between the time frame of 2017-2019 to elucidate both standardized and variable aspects 
practiced by researchers for both identification and quantitation in lipidomics.  
We focus to the importance of the topic and to orient current method validation towards factors (e.g. 
gradient, adducts) yet undecided in the lipidomic community and to clarify the choices made in 
lipidomic analyses. Moreover, complex lipidomic data demands high-throughput data processing as 
well as the appropriate chemometric and statistical tools, which are also represented in the review. 
The manuscript contains 4 figures and 5 tables. Among them, Figure 4 needs permission for 
reprinting.  
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Abstract 
The review concentrates on the properties of analytical and statistical ultrahigh-performance 
liquid chromatographic (UHPLC) – mass spectrometric (MS) methods suitable for glycero-, 
glycerophospho- and sphingolipids in lipidomics published between the years 2017-2019. 
Trends and fluctuations of conventional and nano-UHPLC methods with MS and tandem MS 
detection were observed in context of analysis conditions and tools used for data-analysis. 
Whereas general workflow characteristics are agreed upon, more details related to the 
chromatographic methodology (i.e. stationary and mobile phase conditions) need evidently 
agreements. Lipid quantitation relies upon isotope-labelled standards in targeted analyses and 
fully standardless algorithm-based untargeted analyses. Furthermore, a wide spectrum of 
setups have shown potential for the elucidation of complex and large datasets by minimizing 
the risks of systematic misinterpretation like false positives. This kind of evaluation was shown 
to have increased importance and usage for cross-validation and data-analysis. 
Keywords 
Lipidomics, mass spectrometry, ultrahigh performance liquid chromatography, nano-liquid 





• Method development and application enhancements in lipidomics 
• The review sums up chemometric and statistical methods for current lipidomics 
• State of the art data collection and evaluation is discussed 
• Identification/quantitation of biological lipids 
• Tandem MS data-independent and data-dependent analysis 
Abbreviations 
ACP acyl carrier protein, AF4 asymmetric flow field flow fractionation, ANOVA analysis of 
variance, AUC area under curve, CARS coherent anti-Stokes Raman scattering, CCS collision 
cross-section, CN total carbon, CRS coherent Raman scattering, DB double bond, DDA data 
dependent acquisition, DESI desorption electrospray ionization, DG diacylglycerol, DIA data 
independent acquisition, DIMS direct infusion MS, FDR false discovery rate, FA fatty acyl, 
FFA free fatty acid, GC gas chromatography, GL glycerolipid, GP glycerophospholipid, HCA 
hierarchical cluster analysis, i.d. internal diameter, IMS ion mobility spectrometry, HPLC 
liquid chromatography, LESA liquid extraction surface analysis, m/z mass-to-charge [ratio], 
LSI Lipidomic Standards Initiative, HR/LRMS high/low resolution mass spectrometry, MSE 
all ions scans, MS/MS tandem mass spectrometry, MS/MS/MS second-generation 
fragmentation mass spectrometry MSn  on-line coupled mass spectrometry system, MSI mass 
spectrometric imaging, m/z mass-to-charge ratio, NP normal phase, NSI nano-electrospray 
ionization,  nESI negative ion mode in electrospray ionization, OPLS-DA orthogonal 
projections to latent structures discriminant analysis, (L)PA (lyso-)phosphatidic acid, (L)PC 
(lyso-)phosphatidylcholine, (L)PE lyso-phosphatidylethanolamine, pESI positive ion mode in 
electrospray ionization, (L)PG (lyso-) phospatidylglycerol, (L)PI (lyso-)phosphatidylinositol, 
NP-HPLC normal phase liquid chromatography, PIS precursor ion scan, PLS-DA partial least 




)phosphatidylserine, QqQ triple quadrupole mass analyzer, QTOF quadrupole - time of flight, 
ROC receiver operating characteristics curve, RP-HPLC reversed phase liquid 
chromatography, RT retention time, SP sphingolipid, SFC supercritical fluid chromatography, 
SWATH sequential window acquisition of all theoretical fragment ion mass spectra, SWARM 
sliding window adduct removal method, TG triacylglycerol, TOF time of flight mass analyzer, 
UHPLC ultra-high performance liquid chromatography, VIP variable importance projection 
1. Introduction 
Recent lipid research has emerged due to improved multidimensional computer algorithms and 
highly efficient commercial, open-source and in-house software platforms. Furthermore, data 
libraries for automated routine searching of mass spectra is adopted for lipid identification. 
International organizations have started together to harmonize knowledge about lipidomics. 
Especially, the Lipidomics Standard Initiative (LSI, https://lipidomics-standards-
initiative.org/) found under the International Lipidomic Society 
(https://lipidomicssociety.org/about/) and Lipid Home (https://www.lipidhome.co.uk/) strive 
to standardize lipidomic information with the globally acknowledged platform Lipid MAPS 
(https://www.lipidmaps.org/). Furthermore, Sumner et al. [1] have stated minimal requirements 
for retraceable lipid analyses, [1] which are important for integrated research in lipidomics. 
This review on lipid investigatios encompasses research conducted with ultra-high 
performance mass spectrometry (UHPLC-MS) during 2017-2019 [2-79]. To clarify, this 
review uses the term high performance liquid chromatography (HPLC) to describe both 
conventional HPLC and UHPLC. However, blindspots of exclusive UHPLC-research are 
attempted to be covered in the Discussion-section.  
Particularly, half of the reviewed studies deal with computerized platforms to identify lipid 
species of several classes. These computerized platforms have successfully enabled data 




all, the most popular means of comprehensive identification in -omics research is on-line 
coupled mass spectrometry systems (MSn, e.g. tandem mass spectrometry [MS/MS]), which 
demand extensive and thorough data-handling. In the field of lipidomics, MSn is often divided 
into data-dependent acquisition (DDA) and data-independent acquisition (DIA). Here, DDA is 
typically defined as fragmentation of only targeted precursors, as is the case in parallel reaction 
monitoring (PRM) [15], [44], [45]. It is a technique, in which all fragments of the chosen lipid 
precursors are measured. In DIA, all available lipid precursors are fragmented and measured 
in a full scan with a set of collision energy (CE) or energies, detecting a substantial amount of 
lipid adducts fragmentation patterns, e.g. in an all ions scan (MSE) [9-15], [32-34], [55-61], 
[68], [74]. 
Recent DIA research were applied in a novel MS technique called sequential window 
acquisition of all theoretical fragment ions spectra (SWATH MS) [6], [44], [73-76] and 
similarly, with QTOF-specific SONAR technology [69]. The consecutive fragmentation or 
scan of precursors (i.e. PRM for DDA and SWATH or SONAR for DIA) and their product ions 
provide cleaner MS spectra in favour of library searches, an improved detection rate, broadened 
range, and expanded specificity in any given fragmentation frame compared to other methods 
[34], [44], [73], [69]. Different MS and MS/MS techniques are compiled in Table 1. When 
significant, instrumental and experimental conditions for glycero-, glycerophospho- and 
sphingolipids are focused on and referred to [80-88]. 
2 Fatty acids, lipids and metabolites of the survey 
Fatty acids are synthetized in cells and their cell membranes, endoplasmatic reticulum, Golgi 
apparatus, and mitochondria [89], [90]. Most lipids are products of free fatty acids in presence 
of coenzyme A and NADPH [91]. This literature survey deals with a short area of lipidomics 
and contains commonly studied lipids, e.g. glycerolipids (GLs) like mono- (MG), di- (diacyl-, 




lipids in analytics, Figure 1 illustrates the functionalities of TG lipids. Glycerophospholipids 
(GPs) from GLs are also included, since they are frequently detected like the most abundant 
lipids in eukaryotic cells, i.e. phosphatidylcholine (PC) and phosphatidylethanolamine (PE) 
[92]. Other GPs dealt in this review include phosphatidic acid (PA), phosphatidylserine (PS), 
phosphatidylinositol (PI), phosphatidylglycerols (PGs), and PG-derived cardiolipins (CLs). 
[92] To observe the challenges of separation and identification issues some glycerolipids and 
glycerophospholipids are illustrated in Figure 2.  
GPs may appear with fatty acids which both are bound with ester or ether groups, the latter 
being defined as plasmalogens (PLs) [92]. PLs are detected and identified either by an alkenyl 
linker with an oxygen (e.g. PI[O-18:0/17:0]) or with a phosphorous (e.g. PI[P-18:0/17:0]) [92]. 
Those structural hetero atoms help mass spectrometric detection, although there may not be 
improvements in chromatographic separation.  
An interesting group of surveyed lipids is sphingolipids (SPs, Figure 3, [28]). They have a 
basic backbone with various kinds of lipids. The backbone is formed from serine amino acid 
and a long-chain fatty acyl catalyzed by coenzyme A in mammals [92]. The analytics is focused 
to ceramides (Cer), which have amine-bonds with fatty acids.  To sum up, interest is focused 
on esterified fatty acids with glycerol head groups (glycerolipids, glycerophospholipids) or a 
sphingosine headgroup (sphingolipids), but not a sugar backbone (saccharolipids, a topic of 
worth its own review). Other groups left out are defined by characteristic hydrocarbon 
structures, i.e. fatty acyls, prenol lipids, sterols and polyketides [94]. More analysis on lipid 
classes and metabolism is discussed elsewhere [101]  
3 Instrumentation 
In lipidomics, a wide range of articles introduce new or improved methods which are validated 
with UHPLC-MS, capillary-UHPLC-MS (nUHPLC-MS or nano-UHPLC-MS) instruments 




development of chromatographic methods [9], [22], [27], [45], MS/MS identification [7], [16], 
[23], [27], computational methods for improvement of measurement performance [17], and 
data analysis [21], [25], [96]. Recent challenges in HPLC-MS seem to be fluctuation 
(repeatability) of analysis [97], [98] results, which hinder reliable identification and inter-
laboratory tests of lipids. Since in chromatographic environments elution of different lipid 
types and their species may differ [98], deconvolution of data via manual or computational 
analysis may be the only reasonable compromise. 
The reviewed papers show that all lipid analyses have fluctuation of lipid composition and 
intensity based on the fingerprint profiles of different biological matrices. These observations 
can be explained by distinctive matrix effects, which in turn inform that there is a specific need 
of sample preparation before analyses. Usually, lipidome studies are done with simplified 
sample preparation to avoid recovery losses in clean-up steps. [99] Mostly, the clean-up steps 
are protein precipitation and extraction of solid matrix compounds (e.g. biological tissues) and 
fluids (e.g. plasma, serum, lavages, cell suspensions and supernatants).[99] Furthermore, solid 
materials may trap internal standards and analytes, which increases variation of results in 
quantification and leads to less accuracy and precision of the methods. [100] Sample 
preparation of biological and clinical samples is discussed more elsewhere [101].  
Though reconstitution with the most used polar acetonitrile - water mixture (60:40, v/v) and 
organic isopropanol - acetonitrile (90:10, v/v) eluents is practical, none of these dissolve lipids 
comprehensively. For instance, acetonitrile - water at 60:40 (v/v) recovers STs and TGs 
incompletely. [45] Furthermore, Danne-Rasche et al. [45] observed a distortion or even loss of 
lipids with i-propanol - acetonitrile mixture (9:1, v/v),  when the eluent was used in nano-
UHPLC. Thus, lipids need to  be reconstituted into a standardized mixture such as butanol - i-
propanol - water (8:23:69, v/v/v) [45] prior to injection. The solvent composition is important 




sample preparation, all lipid samples need to be dried for getting concentrates of HPLC-MS 
research. Furthermore, concentrates are needed to measure multidimensional MS spectra to 
obtain accurate identification and algorithm-based data handling of features.  
To reduce systematic noise and other disadvantages (e.g. adsorption, peak broadening, adduct 
formation) in chromatographic data has been attempted via computational methods, i.e. with 
the sliding window adduct removal method (SWARM). [102] SWARM is based on the 
systematic interference caused by multiple adduct ions of the same analyte. The interference 
induces systematic noise patterns that may be excluded to enhance accurate mass acquisition 
for metabolites. Then, the adduct signal overlap correction for low-to-moderate resolution mass 
spectra could be utilized. 
Modern instrumental separation and detection methodologies are still on-going needed to avoid 
frequent appearance of false negative lipid identifications and to establish sufficiently reliable 
and label-free (i.e. standard-free) methods. Identification of lipids showed to be improved by 
multiply usability of analytical variables and by using more independent properties, such as 
chromatographic retention times (RT) and mass spectrometric mass-to-charge ratios (m/z) of 
lipid ions/adducts, fragmentation/isotope patterns, and collision reactions. Reliability for 
targeted lipid species identified by internal standards and calibrants have made lipid analyses 
possible in quite many case, but especially non-targeted lipid analyses demand the super power 
and speed of computers with algorithm-based libraries.[96], [103], [104] Thus, the analyses 
can be independently conducted without potent analytes. Evidently, the computerized methods 
have utilized automated systems when internal standards for normalization are neglected. [2], 
[3], [10], [11], [13], [14], [16], [17], [20], [21], [22], [24], [26], [30], [32-36], [38], [44], [4 6], 





HPLC techniques are preferred for their ability to enhance identification by predictable 
retention time patterns [98], [105] and reduced mass ambiguity [106]. In lipid research, the 
sub-method UHPLC is preferred over HPLC due to its lower dispersion, substantial decrease 
in solvent usage, shorter analysis times without compromising resolution, higher resolution 
performance due to smaller (sub-2 µm) fully porous particles or (sub-3 µm) core-shell material 
[73] in columns (enabled by higher pressure capabilities) and enhanced retention precision. 
[107] 
Our dataset [2-79], [108] informs current lipidomic UHPLC-MS separations to be primarily 
done with additive-assisted reversed phase liquid chromatography (RP-HPLC) hyphenated 
with separate experiments on positive electrospray ionization (pESI) and negative electrospray 
ionization (nESI). Though ESI was predominantly used for UHPLC-MS, some atmospheric 
pressure chemical ionization (APCI) studies were also conducted. [23], [44], [47]. ESI as a 
‘soft’ and APCI as a ‘hard’ ionization technique, respectively, are suitable for supporting lipid 
identification. [23] In respect of that, Beccaria et al. [23] developed a method suitable for both 
detection approaches with no need to change HPLC parameters.  
Elution of lipids in HPLC is done in many elution models (e.g. isocratic elution, curved 
gradient following an exponential or logarithmic function, stepped gradient, linear gradient, 
etc.). The suitable stationary and mobile phases with methods are also found in Table 1. More 
detailed information on stationary and mobile phases as well as lipid adduct concentrations is 
in Supplementary (Table S1). 
3.1.1 Reversed phase separation in HPLC 
In lipidomics the commonly used RP-HPLC separation methods are based on the interaction 
of a nonpolar stationary phase with nonpolar lipid analytes. Nonlinear or second-degree curves 
between the retention times and total carbon (CN) double bonds (DB) are used for quantitative 




adducts from similar exact masses (e.g. [PC(38:4)+Na]+ and [PC(40:7)+H]+ [9]). However, 
retention time prediction can be complicated due to pH dependent speciation [109], 
experimentally made validation and multi-step liquid gradients [23].  Separation of polar 
components (i.e. early retaining lipids) can be affected by the mobile phase gradient. When 
elution is started with high percentage of organic mixture, polar compounds are longer 
adsorbed and retained on RP-HPLC phases. [110] However, changes of eluent polarity are 
interlinked with the ionization rate of polar lipids, which in turn can have an impact on elution. 
[110] RP-HPLC with polar solvents (i.e. non-aqueous RP-HPLC) is enabled by polymer-based 
columns which are end-capped by a methyl or hydrogen group. [110] Some column materials 
are based on modified silica, which when not shielded are short-periodically used with water 
modified organic solvents due to free silanol groups having the attractive functions. [110] 
In contrast to phenomena in reversed phases, normal phases in HPLC (NP-HPLC) typically 
separates analytes containing polar  functionalities having silanol, amino- or diol groups. [111] 
NP-HPLC is excluded from the review, since only a single article on NP-HPLC with amide 
column was observed during 2017-2019 on lipid separation [31]. 
Since even the variation among lipid class species can be substantial, it is not surprising that 
the polarity of their classes varies a lot. Tumanov and Kamphorst [85] (Figure 4) demonstrated 
the lipid-subclass range of four distinct chromatographic approaches, which are divided to two 
groups (one a RP, one a NP separation strategy in each group). The subclasses in (A) include 
lipids of the nonpolar kind, whereas the separations of (B) are modelled to the polar lipid 
subclasses. Particularly, polar (lyso-forms, MGs, sphingosine-related compounds, FAs, acyl 
carnitines and acetyl coenzyme A) and mid-polar (PS, PG, PI, Cer) lipids seem to be species 
often analysed with the negative ionization mode, though more species are primarily found 
with positive ionization. From the GLs only MGs have FA chains with 16 counts, i.e. they are 




they have amide-bound FA chains. [85] Thus for reliable research data, accurate UHPLC-MS 
methods are needed to identify the individual lipid class species.  
3.1.2 HILIC 
Essentially, hydrophilic interaction liquid chromatography (HILIC) columns are micro-bore 
columns with stationary phases of mixed hydrophilic interactions for nonpolar compounds and 
hydrophobic interactions for polar compounds. However, nonpolar lipids (e.g. CEs, TGs) and 
lipids with only one hydroxyl group (e.g. Cer, DG, MG, and cholesterol) are often barely 
retained. [16] Nevertheless, HILIC is a well-established subclass of NP chromatography that 
allows usage of water as the eluent (5-40%, >2% needed) as in contrast to conventional NP. 
[112] HILIC platforms are ideal for quantitation, since lipid class species co-elute with their 
respective calibrants. [109]  
PAs and PSs species are known to have broad or barely detectable peaks in RP-HPLC, thus, 
HILIC is used. [112] Furthermore, as PAs and LPAs co-elute among major lipid components 
(e.g. PCs, PEs, SMs) in RP-HPLC. Because of that the comparatively lower abundance of lipids 
in this class, PAs and LPAs have no selective fragment to differentiate from other lipid classes. 
Thus, proper methods for PA/LPA separation have been specifically approached with HILIC. 
[113], [109]  
Though being a well-established technique for HPLC-MS quantitation, not many UHPLC 
analyses have used HILIC-columns for separation. [16], [47] Thus, HILIC applications are also 
excluded from the scope of this review. 
3.1.3 Nano-UHPLC 
In nano-HPLC [112] columns of sub-millimetre internal diameter (i.d.) are filled with 
conventional column packing materials. Published papers [41], [71], [24], [45], [42] inform 
only about using a loaded capillary (i.d.: 1-0.001 mm [114]) or a nanobore column (i.d.: 0.1-




smallest possible narrow bore columns (2.1-4 mm). Surprisingly, along with nano-HPLC a 
low-resolution triple-quadrupole mass spectrometer was unequivocally preferred.  
In contrast to a faster UHPLC separation, in nano-HPLC the “loading time” followed by the 
sample elution was extended due to the low flow rate restrictions (0.3-0.35 μl/min). [71]  
Nano-HPLC methods show a great capacity for lipid identification with a low-resolution mass 
analyser, since then both an extremely broad identification range and high sensitivity at the low 
fmol-scale are gained using a low throughput (analysis time: 40-60 min). [41], [45] The result 
was that the low fmol range for almost every GLs, GPs, SPs and their lipid derivatives was 
reached in the positive ionization electrospray mode (pESI). For example, the calibration curve 
for a specific PE (17:0/14:1) demonstrated a linear relationship between 16-10000 fmol by 
pESI-MS detection and 0.64-2000 fmol by nESI-MS detection [41] By contrast, with HPLC-
ESI-MS the linear dynamic range for the same analyte reached around 80-10000 fmol by pESI-
MS and 16-2000 fmol by nESI-MS. [45] Similarly, Kim et al. [115] achieved a LOD-range 
from 59 fmol (LPC(17:0)) to 507 fmol (LPG(14:0)) with untargeted nano-UHPLC-ESI-
MS/MS of lipoprotein by pESI and nESI ionization, respectively. [115] 
3.1.4 Mobile phases in hyphenation of HPLC with MS 
Mobile phases in HPLC are usually modified to help in lipid detection and their separation with 
HPLC. [112] As the sensitivity issues are concerned, composition of eluents is important to 
obtain stabile adduct ions in MS. [23] Volatile buffers (e.g. formic acid, acetic acid, or their 
ammonium salts [116]) are used in lipidomics methods. [113] However, earlier studies report 
lipid results with 5 µM phosphate buffer (nanoelectrospray ionization) [9] and 5 mM 
phosphoric acid [45]  
In some cases, additives in HPLC eluents may cause analytes to become undetectable due to 
signal suppression. Cajka and Fiehn [117] studied the effects of five different modifiers in both 




(BEH) particles and the slightly better charged surface hybrid (CSH) particles. [117] Whereas 
the experiments could be concluded by choosing the optimal mobile phase modifier to be 
formic acid or formic acid/ammonium acetate for pESI and ammonium acetate for nESI. Using 
a CSH C18 column with HPLC-pESI-MS studies Monnin et al. [118] reported about a further 
enhanced ionization efficiency by choosing 0.02% acetic acid as the additive in eluent. 
Whereas the signal for LPLs (except LSM) and GPs certainly increased by manifold, Cer and 
PCs experienced a decrease in peak area when compared with analyses data with 10 mM 
ammonium acetate. [118] However, specific to PCs their carbonate ion adducts showed 20-
fold stronger signals compared to their ammonium adducts with CID-MS/MS. [119] 
3.2 Importance of mass spectrometry detection in lipid research 
Formation of adducts is dependent on the molecular structure and functional groups of a lipid 
(e.g. deprotonation of carboxyl groups in fatty acid with nESI). Lists of exact masses in MS 
and MS/MS, non-protonated adducts, possible collision energies and lipid classes/topics are 
listed in Table 3. Furthermore, sources like Lipid maps providing a free MS/MS prediction 
tool (http://lipidmaps.org/resources/tools/index.php) and a structure database library 
(http://lipidmaps.org/data/classification/LM_classification_exp.php) allow data handling in 
lipidomics. 
MS advancements, such as a quadrupole Orbitrap mass analyzer (Q-Orbitrap) [9], [17], [20], 
[22], [27], [31], [46], [49], [51], [55], [56], [62-65], [77], [79], and NSI [24], [45], [71] have 
extremely increased resolution capabilities (theoretical plate number in HPLC >35 000 /m) for 
lipid identification. However, compromises need to be done before the analyses, since either 
mass accuracy or ion resolution is emphasized depending on whether identification or 
quantitation is preferred. Furthermore, identification is improved with the help of orthogonal 
measurements, such as collisional cross-section (CCS) values with ion mobility spectrometry 




flight (QTOF) [6], [16], [25], [68]. Furthermore, the inclusion of trapped IMS (TIMS) 
combined with parallel accumulation serial fragmentation (PASEF) has emerged to enhance 
complementary MS/MS and IMS data. [126] 
For high-resolution MS, an Orbitrap [2], [5], [34], QTOF [4], [6], [10-16], [21], [25], [28], 
[30], [32], [33], [36-40], [43], [44], [53], [54], [59-61], [66], [68-71], [71], AA073, [74], [75], 
AA076, [78] and QOrbitrap [3], [5], [9], [17-20], [22],  [26],  [27],  [31], [34], [35], [46], [47], 
[49-51], [55-58], [60], [62-65], [72], [77], [79] were used. However, some studies settled for 
low-resolution MS, mostly with a triple quadrupole instrument [7], [8], [23], [24], [30], [41-
43]. Most rarely, pseudotargeted methods [21], [30], [54] (i.e. lipid identification with an in 
silico library), polarity switching [5], [17], [23], [41], [49], standalone nESI mode in MS [29], 
[43], [68], NSI [45], [71] and atmospheric pressure chemical ionization (APCI) [23], [44], [47] 
were used.  
3.3 Data acquisition and processing 
Identification and determination of lipids and their metabolites need commercial, open-source, 
and sophisticated tailor-made tools [127]. The statistical tools, analysis software, and 
algorithms enable visualization and perceiving of patterns from large datasets and raw data 
[103]. Metabolic profiling of MS data is done with multi-variant programs, such as 
Metaboanalyst, [10], [11], [17], [27], [32], [34], [37], [40], [46], [59], [63], [77] or MeV [3], 
[30], [65], [61], [79], [103],. All in all, reported software environments for data processing 
constitute mostly of R and SPSS languages.  
Manual programming from the ground up or with borrowed code demands more computational 
expertise. Koelmel et al. [96] compared identification algorithms with the commercial R-based 
LipidMatch-tool, which is tailored for lipid identification softwares. [96] For a deeper 




automated workflow for rule-based lipid identification using untargeted high-resolution 
tandem mass spectrometry data“ gives excellent information [96].  
4 Analysis 
4.1 Identification of lipids  
Lipid identification can be enhanced by using information about the individual lipid itself, e.g. 
by increasing orthogonal information via “polarity switching” [5], [17], [23], [41], [49] instead 
of only using one ionization mode in the measurements or by the introduction of supporting 
measurements or (lipid class) expanding methods. Identification demands are partly already 
mentioned in Introduction and chapters, where chromatographic parameters are discussed 
referenced to resolution and sensitivity. 
In lipid studies, absolute retention time (RT) variation during sample analyses is easily 
increased by small differences in experimental conditions (preparatory, chromatographic, and 
instrumental parameters). However, more repeatable separation techniques along with feature 
alignment enables more reliable identification with RTs in inter-laboratory studies in the future. 
[128] Since measurements of m/z ratio are significantly less deviant (parameters affecting m/z: 
ionization efficiency and mass spectrometric setup), single m/z, feature, and low-resolution 
spectra matching are the most used means for quick identification. [7] If needed, high 
resolution precursor and product ion spectra are usually obtained to achieve accurate 
identification between highly similar species. For further optimization of mass spectrometric 
identification, adduct formation and control of collision energy should also be studied and used. 
It is commonly agreed that adduct ions are formed mostly during ionization [9], [73], which is 
why lipid species appear at the same retention time in both pESI-MS and nESI-MS. Apart from 
protonated and deprotonated species, adding of millimolar concentrations of salts can be 
harnessed for signal enhancement [129]. Though at too high concentrations lipid signals can 




ions are acetate (CH3COO
-) [56], [68], formate (HCOO-) [48], [50], [57], [58], [60], [75-77], 
and ammonium (NH4
+) [48], [50], [56-58], [60], [74-76]. Sodium (Na+) and potassium (K+) 
adducts are also commonly observed, though no controlled addition of such salts was noticed 
[92]. 
High resolution RP-HPLC separates structural isomers of lipid classes, [9] up to the point of 
carbon chain regioisomers (i.e. sn-positions of lipids). However, comprehensive identification 
of isobars and isomers could not be achieved by solely using MS/MS. For example, Lisa et al. 
[16] and Blaženović et al. [25] reported unresolved isomers and isobars with identical CNs and 
DBs but different fatty acyl composition. Adducts with same nominal mass can be separated 
with MS/MS [23], but specific information like sn-position of DBs needs other methods, like 
derivatizing of free fatty acids to form 4-iodobenzyl esters [130]. The reaction is made to 
esterified fatty acids into distinguishable epoxides via  ketone dioxide catalyst and oxidant 
[131] or to oxetane-adducts via the Paternó-Büchi photochemical reaction. [132], [133], [134] 
Mass spectrometric solutions include second-generation fragmentation (MS/MS/MS) by dual 
stage collision-induced dissociation (CID) [135] or CID and ozone-induced dissociation 
combined, or silver-ion chromatography (currently achieved only with TGs) [81], [112], [136]. 
Recently, Zhao et al. [119] also mentioned electron impact excitation of ions from organics 
(EIEIO) and photo-ultraviolet dissociation (PUVD, photodissociation [130]) in the list of non-
CID methods for sn and DB position.  Since lyso-forms of GPs, i.e. sn-2 acyl lipids retain less 
in a HPLC column than their sn-1 isomers, they can be identified as separated double peaks. 
[9]  
4.2 Quantification of lipids 
Burla et al. [99] (a statement of the global lipidome community) compiled guideline 
recommendations for quantitative analysis in clinical sample matrices, specifically absolute 




quantification results, lipid concentrations should be reported in the SI-units mol/L or molar 
percentages whenever possible. [99] 
In comparison to lipid identification, quantitative analysis is increasingly dependent on control 
samples as well as the quality and concentration of included standards, i.e. internal standards 
and calibrants. Common control samples include blanks and quality control (QC): Blanks are 
included for standard impurity monitoring and validation purposes, whereas QC samples (a 
pooled sample of all study samples in a batch) serves to monitor and correct batch-related 
uncertainty, instrumental errors and evaluate the performance of lipid analytes for validation 
purposes. [99]  
Absolute quantitative calibration of lipids is either conducted via spiked QC samples (surrogate 
calibration) or by direct introduction of standards in the study sample as is often done in single-
point and standard addition calibration. [75] However, single-point calibrations are reported to 
overestimate target lipid concentrations due to inherent flaws in the regression. [75] An ideal 
calibrant for complex matrices has an identical response factor, ionization efficiency and 
experiences comparable matrix effects as the analyte. [137]  
For better understanding quantitative UHPLC-MS, some differences between HPLC-MS and 
DIMS should be pointed out. Though DIMS is more robust at the high-concentration lipids 
(µmol/L-mmol/L) of a sample, HPLC-MS is advantageous for the identification and 
quantification of low- and very low-abundance lipids (<nmol/L-mmol/L). [137], [99] Anyway, 
lipid class coverage and sensitivity are considerably improved in HPLC-MS experiments. [99] 
As an inherent disadvantage in HPLC-MS, the risk of lipid-lipid interaction increases due to 
the enrichment of same lipid species occurring in the column, though hetero-interaction 
between different lipid species decreases. [137] HPLC-MS uses peak areas in contrast to 




Moreover, the fluctuating quality and quantity of molecular species in the ion source is a 
recurring problem for lipid quantifications. These issues are amplified by the increasing 
complexity of experimental setups, such as chromatographic gradients affecting electrical 
properties (i.e. ionization efficiency) of the eluent. This has implications not only for the 
ionization efficiency, but also for the MS instrument’s response factor: alongside solvent 
composition, Drotleff et al. [75] reports post-acquisition MSn procedures like SWATH or 
multiple reaction monitoring (MRM) to further deviate the detector’s response values from one 
unit per molecule. Drotleff et al. [75] proposed “post-acquisition recalibration” as a reasonable 
compromise, if not enough sample is available for using the standard addition method. Then, 
sensitivities of analytes can be determined via a certified reference material. For lipids, only 
the NIST CRM 1950 plasma reference is currently acknowledged. [75] Standard mixtures, such 
as the Splash® Lipidomix® mixture (Avanti Polar Lipids Inc., Alabaster, AL, USA) have been 
used for mimicking corresponding lipid concentrations in experiments as in biological fluids, 
e.g. human plasma, and for normalization of the analyses [14], [28], [66]. Since lipidome 
isotope labelling of yeast (LILY, complete lipidome carbon labelling with C13 isotope [138]) 
technology is discovered very recently, studies on using it in practice could not be considered 
in this review. 
Furthermore, solvent-system dependent lipid concentrations of >10-100 mmol/L are reported 
to form significant amounts of poorly ionic lipid aggregates (results found in a DIMS 
experiment). [137] The formation of aggregates like dimer, oligomer and micellar structures is 
further increased by the hydrophobicity of the lipid analyte and polarity of the mobile phase. 
[137]  
Biological matrices include inherent variation in concentrations. UHPLC-MS experiments 
mostly revolve relative quantification and study changes in the lipidome of biological systems. 




quantification of targeted lipids. [99] Main limitations of absolute quantification in HPLC-MS 
concern ambiguities preceding calibration, i.e. the structural versatility of lipid species, lipid 
concentrations at the lower (or upper) border of their linearity range, and various matrix effects 
such as ion suppression and enhancement. [99] Whereas polar lipid species quantification 
reaches a ~5% accuracy (due to the polar headgroup predominantly explains their MS 
sensitivity) [137]. Mid- to nonpolar lipids like TGs and cholesteric esters are more effected by 
their specific structure in ESI-MS. [104] Thus, these lipids need more attention in standard 
representation. More details on quantitative and validation in lipid analyses are informed in 
Refs. [99] and [104].  
5 Data analysis of lipids 
According to the lipidome community, experimentally acquired raw data should be available 
for result-validation purposes and study re-analysis, whereas analytical details and results 
should be included in a file with acknowledged “XML[-based] or structured tabular format”. 
[99] Corresponding raw data information can be taken from the proteomic field, which has 
practical formats for efficient data sharing. [99] 
5.1 Normalization 
Normalization of raw data is used to reduce systematic fluctuation concerning an accurate 
measurement. For example, Boysen et al. [139] developed the best matched internal standard 
normalization (B-MIS), an algorithm-driven solution for correcting non-biological variation of 
raw data (i.e. ion suppression by matrix effects, chromatographic quality and analytical drift). 
Obscuring variation, i.e. changes of peak area as a function of concentration, is compared 
between an unrestricted set of internal standards and analyte peaks in a QC sample. As a result, 
the algorithm chooses a suitable standard for normalization if the relative standard deviation of 
the peak area is improved by 40%. [139] Furthermore, Drotleff et al. [76] considered B-MIS 




variation, median absolute deviation and variance. His team observed a small difference in real 
positives favouring this normalization, but also noted that normalization models may work in 
a complementary fashion with their respective strengths and weaknesses. [76] Though not yet 
applied in absolute quantification experiments, B-MIS appears as a good alternative for model-
based peak area normalization in relative quantification methods. [139], [76]  
Normalization is done with single standards representing the whole range of lipid classes. 
Suitable internal calibration standards with the same head groups and similar, but not identical 
fatty acids (e.g. odd-numbered <1% abundant in higher organisms [104]), or isotope-labeled 
fatty acids are preferred for normalization [104]. The most used internal standards are 
deuterated at the carbon chain of their FA end to have either 7 or 9 deuterium atoms. [75] 
Internal standards included in QC samples are used for post-correction of systematic errors (i.e. 
drift and other batch-biases) [104], [99] like changes in peak shapes influencing the peak areas 
and for monitoring carry over [112].  
5.2 Data libraries  
Typically, lipid metabolite features in untargeted analyses are compared to available library 
spectra. [66], [118] Therefore, acquired data is represented by a “closest-match” for the m/z or 
total ion spectrum that is compared, typically accompanied by a score from 1-100%. Evidently, 
this approach may lead to false positive results, when the database used is incomplete or when 
the reference data is noisy [128]. 
Along with home-made databases [30], [32], [33], [36], [51], [54], [68], [78], commercial and 
open-source libraries have gained popularity and variety both for monitoring the lipid range 
with MS by characterizing fragmentation patterns for selective identity searching of lipids. 
Information about individual libraries and their respective types are compiled in Table 4. 
Specific tools like open-source softwares are mentioned in Table 5, whereas chemometric and 




from the LSI document (https://lipidomics-standards-initiative.org/links) and LIPID MAPS 
pages (http://lipidmaps.org/resources/tools/index.php). 
5.3 Chemometric tools 
Typically, metabolic correlation and significance analyses of lipids is conducted with a set of 
visual chemometric analyses and statistical methods. Chemometric methods provide an 
overview on analyte trends and outliers in relationship to their observations (features, spectra, 
etc.) with principal component analysis (PCA) [5], [7], [13], [16], [17-19], [27], [30], [31], [33-
36], [38-40], [43], [47-49], [51], [52], [54], [56-60], [62-64], [66], [68], [69], [72], [73], [75-
79], [124], systematic but hidden/uncorrelated variation between lipidome states with partial 
least-squares regression – discriminant analysis (PLS-DA) [3], [7], [10], [11], [26], [32], [34], 
[35], [48], [59], [60], [64], [76], [79], or orthogonal projection of latent structures – 
discriminant analysis (OPLS-DA) [4], [6], [9], [19], [27], [33], [36], [37], [49], [50], [52], [54], 
[57], [60], [69], [78], [79], (relative or exact) concentration evaluation with boxplots [10], [18], 
[19], [32], [34], [37], [40], [44], [45], [48], [58], [60], [61], [67], [69], [73], [76] or a heatmap 
[3], [5], [7], [10], [11], [17], [26-28], [30-32], [34-38], [40-42], [45], [47], [48], [52], [56-58], 
[62], [68], [69], [73], [77], [79] visualizations for significant outlier detection such as the 
Bland-Altman plot [16], [40], [43-45], [55], analyte interaction or metabolic interlinkage of 
lipid species via hierarchical cluster analysis (HCA, often included with heatmap analysis) [3], 
[5], [7], [10], [17], [26], [27], [34], [37], [39], [40], [47-49], [68], [69], [73], [77], [79], 
interactive network [3], [26], [47] or pathway analysis [3], [7], [11], [26], [27], [37], [60], and 
diagnostic tools such as importance testing of PLS-DA variables  with variable importance 
projection (VIP) [3], [10], [26], [33-37], [48], [50], [52], [57], [64], [79], OPLS-DA variable 
reliability and importance evaluation via S-plots [6], [27], [50], [57], [69], [79] or volcano plots 
[11], [31], [41], [42], [48], [60], [63], [67], [74], [77], [78], and method or sample comparisons 




PCA [140] pursues to flatten a large dataset with multiple variables to find the most important 
two sources of variation, i.e. principal components. This is done by comparing the transitions 
between all variables and flattening them into two dimensions with matrix operations. Thus, 
the most important information about multivariate data is found. This reduction process may 
help to divide the studied compounds into different groups and characterize them. [141] 
Similarly, PLS-DA seeks to flatten multivariate data to find the most fitting parallel two-
dimensional plane representing the whole dataset, [140] whereas OPLS-DA reduces the dataset 
to an orthogonal plane found with the partial least square plateau of the dataset. [142] Briefly, 
HCA clusters and categorizes sample components according to their apparent covariant 
relationship. [143]  
Before actual multivariate data-analysis, the data needs often to be transformed, i.e. cleaned, 
scaled and re-centered, as is often done with e.g. statistical noise corrections or discarding of 
noisy data/spectra/outliers, unit variance or Pareto scaling and mean centering for PCA. [144] 
Chemometric methods, such as PCA, PLS-DA and OPLS-DA have kept their positions as the 
most common tools for visualizing analyte groupings (PCA) and metabolic changes (PLS-DA, 
OPLS-DA). Furthermore, VIP has emerged as an emphasis estimator of PLS-DA variables [3], 
[8], [26], [32], [34], [37], [64], [79] emphasizing the importance (i.e. magnitude) of each 
variable. In this context, lipids in the projection plot with VIP scores >1 are most accountable 
to predict changes in metabolism. More extensive analyses can be found in Ref. [88] 
5.4 Statistical tools 
In lipidomic research, statistical methods have developed into a broad variety of numerical tests 
and visualization techniques. Targeted and untargeted methods are two distinctively different 
approaches, as well as the means of data processing. Gorrochategui et al. [103] divided the 
targeted processing of metabolites into five phases: (1) the acquisition of raw data, (2) the 




analytes, (3) the pre-processing and identification of these metabolites, (4) the normalization 
and quantification of the identified species, and (5) the reflection of the results on the 
biochemical/physiological context of metabolic pathways. [103] In contrast to targeted 
approaches, untargeted approaches need more careful experimental MS data processing, data 
modification, and evaluation for pre-processing to attain sufficient data quality. By this way, 
relevant biomarkers can be identified from the totality of detected features/peaks. The data 
quality is directly affected by the sensitivity and resolving power of the applied 
instrumentation. The non-targeted steps include the same pathway elucidation as in the targeted 
analyses, however, with respective appropriate tools. [103] 
Statistical methods include a null hypothesis to test similarities by using one dataset. However, 
the p-value parameter in the Student’s t-test [2],  [10], [14], [15], [18], [19], [26], [27], [32], 
[37-39], [42], [50], [52], [54], [56], [57], [60], [61], [63], [67], [72], [79],  the non-parametric 
Mann-Whitney U-test, [15], [31], [35], [41], [50], [57], [58], [74], [77], and the analysis of 
variance test (ANOVA) [2], [7], [10], [17], [22], [27], [32], [33], [46], [64], [69], [79] are for 
comparison of two or more datasets. These methods are often used for validation of analytical 
data and for detection of changes (e.g. analyte concentrations) between a control sample and 
authentic samples. Together with statistical tests, correction methods such as the Benjamini-
Hochberg test [145] are used to calculate the false discovery rate (FDR), i.e. minimizing false 
positive data in the dataset [56-58], [60], [74], [76]. 
The t-test designed for comparing two independent variables (e.g. patient versus control group 
lipidome data and that before and after drug intake) may be unreliable, when the sample size 
number is small (n<30) or when other kinds than normal distributions arise through the data 
processing [63]. This is the case for most sample number described in the articles reviewed for 
this paper. The average number of real samples studied was around 10-20 with the excluded 




clear split of 7-16 and ~30 in the number of controls used in the individual studies [30], [34]. 
Some cases of statistical testing of the datasets may be questionable, since e.g. t-tests were not 
reliable, when variances between populations were different.  [146] For these kinds of cases, 
an unequal variance test like the Storey [74], [115] or Welch [48] t-test may be used instead 
[48], [74].    
The Mann-Whitney U-test [147] (also known as the Wilcoxon rank-sum test) is used in 
mathematical data handling, when there are not any fixed parameters, which can be used to 
evaluate similarities of two independent dataset medians with a null hypothesis. For two sets 
with same or different sample sizes, the values of both datasets are sorted from the smallest to 
the largest one. The ranking integer is divided, if two values are identical: for instance, when 
two datapoints have the value 2, they will be both noted as 1.5 [147]. Then, the separately 
ranked sample value sets are individually summed. When any of the sums reaches the critical 
value range of the U-test, the null hypothesis can be rejected.  Akin to the Student´s t-test [63], 
the U-test is evaluated by determining the z-score (𝑧 =
𝑥𝑖−𝜇
𝑆𝐷
, where xi is a value of a single 
datapoint, µ the population mean and SD the population standard deviation) from a normal 
distribution, suitable for a large number of studied samples (>30) [147]. In essence, the z-score 
is a distance-measurement of a single datapoint in relation to a normal distribution’s standard 
deviation, determining the distance between its mean and single measurement. 
A Mann-Whitney U-test [147] can be fitted for non-Gaussian distribution data. It is typically 
combined with a Benjamini-Hochberg (or Bonferroni-Holm [63]) test to exclude false positive 
values, thus providing the FDR. These methods were applied in multiple studies to limit 
uncertainty in the results of lipids. Furthermore, Paepe et al. [27] and Gong et al. [60] used 
cross-validated ANOVA test (CV-ANOVA) to improve reliability of the identified analytes. 




with the Benjamini-Hochberg test [145] were used to discover the real positive results from 
analysed MS datasets.   
In the Benjamini-Hochberg method [145] p-values of two sample sets (between the control and 
the test groups) are inflated mathematically to reveal possible false positive results. Since 
affected and unaffected lipids represent two distinct normal distributions, false positive values 
can be ideally seen to differentiate a distribution from the normal when using a big sample 
number in the study. In the data analysis of lipid species, the original p-values are inflated and 
excluded by their significance desired for the p-values (e.g. p=0.1, 10% significance). The p-
values are then ranked from the smallest to the largest, after which the individual p-values are 
converted to a largest-to-smallest sequence. The largest p-value is kept, but the second largest 
p-value is determined as the smaller value of the two options. Therefore, either it is the same 
value preceding it, or it is the value calculated with a separate equation [145]. 
Lately, Tietz-Bogert et al. [31] calculated the FDR value in a lipido-metabolomic study by 
searching significant biomarkers of primary sclerosing cholangitis [31], which is a disorder of 
lipids in the bile duct of unknown origin. The concentrations of lipid species in control samples 
of healthy individual’s and the clinical samples of sick patient’s blood and bile were compared 
to find changes with a statistical significance of p=0.01 [31]. Simpler classical methods like 
ANOVA for multiple variables [2], [32], [46] were only occasionally used.  
Machine learning and software advancements for multi-ionic identification have allowed to 
evaluate MS spectra produced with UHPLC-MS in silico, which is only demonstrated in a few 
recent articles within our scope [3], [18], [21], [25], [33], [67]. Due to machine learning 
techniques and their discovered use in omics, automated lipidomic analyses, receiver operating 
characteristic curve/area under curve (ROC/AUC) cross-validation analyses [3], [60], [67], 
[76] random forest studies [18], [32], [59], [67], neural network applications [67], [96], in silico 





UHPLC-MS lipidomics is divided into isotope-labelled standard methods and fully 
standardless algorithm-based analyses. Furthermore, the separation and acquisition of highly 
abundant lipid classes (mmol/L) from mid- (µmol/L) and low-abundance (≤nmol/L) classes 
and their species is a challenge. [113] This is especially the case when (semi-)quantitative 
analysis is conducted for all quantifiable lipids in the sample, which can be the case for in-
depth studies on biological materials.  
When comparing matrix effects in pharmacokinetic analysis made with HPLC and supercritical 
fluid chromatography (SFC) coupled with ESI-MS/MS, Svan et al. [148] observed a higher 
amount of ion suppression in SFC than in HPLC due to more ion enhancement. Is this general 
notion also applicable to HPLC-MS in lipidomics? Further information may be obtained from 
matrix effects via post-column infusion [148] as demonstrated by Drotleff et al. [75] or 
observations from more laborious (though more informative) post-extraction process. [149] 
Both of these tools may be important for improving the understanding of lipidome analysis in 
the future, as sightings of such matrix effect analysis is rare in recent lipid papers. 
For practical reasons, a limitation of the comprehensive lipidome analysis is caused by the 
lipids without reasonable sensitivity. [9] Thus, the solution in that case is the Pareto principle, 
i.e. a limited number of biomolecules (lipid species) can be explained and measured using the 
main part of the studied biomass. [9] This is especially understandable in studies, where all the 
components are not relevant to the scientific question proposed. For example, metabolic lipid 
profiling with uncorrelated variation analysis (PLS-DA, OPLS-DA) in combination with 
metabolic knowledge highlight certain lipids from others to determine the most viable 
biomarkers. These biomarkers may form a conjoint array, which can already explain the 




The studies reviewed revealed a constant change, which affect retention time and peak focusing 
in a HPLC method: flow rate, gradient and oven temperature. Apart from an isocratic [43] and 
three-solvent eluents [10], [32], using aqueous - organic solvent gradients by increasing organic 
solvent percentage appeared in stepped (two [21], [40], [48] to three [25], [29], [38], [39] 
plateau steps or two [6], [69] to three [51] inclined steps), curved (exponential, [8], [37], [45], 
[67] logarithmic, [2], [19], [24], [41], [42], [50], [71] or s-curve [20], [27], [39], [49], [59], 
[63], [66]) and most popularly in linear [3], [9], [12], [13], [16], [17], [18], [22], [26], [28], 
[33], [34], [47], [52-54], [56], [67], [78] form. Modifications and combinations such as an 
inverted (i.e. increase in polar solvent percentage) linear [60], [79] or logarithmic [11] gradient, 
pyramidic [57], [77], pit-like [15], modified S-curve [5], [7], [45], [64] linear/isocratic [19], 
[23], exponential/linear [62], [68], [75], exponential/exponential [65], S-curve/exponential [64] 
and S-curve/isocratic [5] gradient were also used.  
In particular, it was observed that the lipid studies were done under various column heating 
temperatures, from room temperature to 65 ˚C. [65] Instrumentation for keeping the oven 
temperature stabile is very important in lipids analysis standardization. Furthermore, the 
research was done under various mobile phase temperatures, i.e. lipid analytes experienced 
significant temperature changes (up to 10-20 ˚C) from column inlet to outlet. [107], [150] In 
addition, as heat is propagated from the column walls to the centre, temperature gradients are 
evident. [107] Though this is partly considered by narrow bore packed columns and the pre-
equilibration of the analyses, the eluents flown from solvent units in room-temperature may 
cool down the column unevenly resulting in separation of lipids with low resolution.  
The choose of column properties in lipid analyses should be considered by sorbent chemistry 
[109], particle size, pore size [86], and particle technology [117]. The unanimously preferred 
column (i.d. 2.1 mm) is not necessarily optimal, since narrower columns are more prone to wall 




bigger columns (internal diameter larger, i.d.). Moreover, a bigger i.d. (3 mm) is argued to 
enhance column efficiency and allow higher flow rates. [107] However, this may be an 
insignificant issue compared to the current disparity in lipidome method standardization and 
validation. [97] 
Avanti Polar Lipids (https://avantilipids.com/tech-support/physical-properties/ionization-
constants) provides pKa-values of phospholipids to be closest to buffer pKa at 2.6 (PS 
phosphate group), 3 (PAs), 2.9-3.5 (PGs) and 5.5 (carboxyl group of PS) when compared to 
the pKa values of formic acid (3.74 [151]) and acetic acid (4.75 [151]). This means that when 
those organic acids are used PSs (and PAs/PGs at low pH) are never once charged ions. Further 
problems may arise for amines such as in sphingosine (pKa 9.1 [152]), PE (9.6 [153]) or PS 
(9.8 [153]) when ammonia (pKa 9.25 [151]) is used. Modifiers used as eluent additives may 
also lead to fluctuations of pH in non-buffered systems in on-line coupled HPLC-MS. [154] 
The phenomena are possible either in the eluent during electrochemical ionization due to 
charge-balancing redox reactions, and during droplet shrinkage, since it may cause structural 
perturbations and discrepancy in the ratios of ionization species. [154] 
In lipidome analytics, interdisciplinary analyses on multifunctional and computational methods 
will be crucial to effective and improved data processing. Furthermore, it is important to use 
the most practical parameters such as precursors, fragments, and CCS values in evaluation of 
data to get fast identification and determination of lipids. Multifunctional methods used are 
statistic and chemometric analyses, whereas computational methods include algorithms, data-
processing interfaces, specific software, and machine learning strategies. Both method 
categories were attempted to be refined with tailored software platforms for necessary data pre-





Concerning common terminology, Aristizabal et al. [155] suggest names depending on the 
acquired structural information: brutto (e.g. PC 36:1), medio (e.g. PC(18:0/18:1), sn-position 
not known), genio (e.g. PC(18:0/18:1), sn-position known) and infinio (e.g. PC(18:0/18:1-9Z), 
sn-position not known). The same research group identified two distinct trends in lipidomics, 
which are the global analysis of lipids (coined macrolipidomics) and the specialized analyses 
for low-abundant lipids (microlipidomics). 
Finally, the recognition correlation of HCA analyses is derived from information often 
visualized in the Heatmaps. Since HCA sorts out (i.e. clusters) groups of similar analyte species 
with each other, similar tools can potentially be developed by means of identifying and 
distinguishing matrices from each other.  
As the scope of this review focuses mainly on UHPLC applications, it may limit some aspects 
of progress in HPLC-MS lipidomics as a whole. However, this was deemed necessary as 
publications on lipidomics have drastically increased. [156], [157] In our opinion -as may be 
representative for lipid studies in general- the most neglected topic mainly left out in the dataset 
was nutritional lipidomics [133] (mainly personalized nutrition [158] and nutritional 
intervention [159] studies). This is in tune with the main tendency of lipidomics towards life-
sciences and bioanalytical questions concerning physiology and pathology. Furthermore, 
UHPLC-IMS-MSn studies were rarer than might be expected from current trends in HPLC-
IMS-MSn lipidomics. Our dataset between the years 2017-2019 (topics discussed elsewhere 
[101]) included research on lipid method development, physiological profiling and metabolic 
changes via multicomponent analysis including drug development and biomarker studies. 
Sample matrices included plants, microbiota, mammals, fish and human patients. [101] 
As UHPLC instruments are less frequent in the total scheme of lipidomics compared to the 
commonly used HPLC instruments, limitations concerning this review’s scope on lipidome 




by Castro-Gómez et al. [15] though some studies use a HPLC-MS ternary gradient separation 
in the fashion of Graeve et al. [160] ; acetone/ethyl acetate (v/v 2:1) and alkane:ethyl acetate 
(alkane: e.g. isooctane or n-heptane, v/v 99.8:0.2)  is applied. [161] The lipidome community 
has also gone out of its way to develop a comprehensive and high-throughput method for lipid 
analysis, which puts emphasis on simple and quick sample preparation, high 
resolution/sensitivity MSn analysis and data handling via extensively automated data 
processing. Consequently, a derivatization step for UHPLC-MS was used only once in our 
dataset [8] where TMSD methylation was applied for separate acidic lipid analysis; neutral and 
basic lipids were directly analysed after sample preparation. [8] Though derivatization may be 
necessary for very low-abundance lipids or to increase lipid class specificity, another reason 
for the reduction of sample preparation steps is the minimization of experimental errors. [137] 
A particularly important outlier in lipidome applications was the research on double bond 
position elucidation; for the absolute determination of double bond positions, other options 
than multiple collision MSn-experiments or spectral library matching have been developed.  
7 Conclusions 
Current challenges in lipidomics are closely related to the lack of uniform methods across the 
field. Compared with the lipid research generally made with RP-HPLC-MS, UHPLC-MS 
needs more focus on the chromatographic method parameters, such as stationary (e.g. column 
choice, oven temperature) and mobile phase properties (flow rate, pH, solvents, gradients, 
eluent modifiers).  
Normalization with representative or single internal standards has been widely adopted in the 
field. Since computational methods alongside chemometric and statistical methods have 
increased in both importance and usage in HPLC-MS technology for cross-validation and data-
analysis, lipidomics needs interdisciplinary studies to reach full potential with big and complex 




parts: Pre-processing, identification/quantitation, chemometric, and statistical analyses. A 
substantial amount of specific processing tools are provided, i.e. commercial and open-source 
ones, including self-made algorithms. Since ever, more lipid libraries have emerged as well for 
untargeted, relatively targeted and in silico methods. Currently, chemometric analyses appear 
to be popular in lipidomics, i.e. for developing methods, profiling lipids in samples, and 
evaluating metabolic relationships between lipid species. For accurate identification, ion 
mobility mass spectrometry has been applied with liquid chromatography, alongside 
chromatographic separation modes with mass-spectrometric ionization, or/and MSn systems. 
When chemometric methods shed light to the inter- and intra-analyte properties of typically 
biological medium, statistical analyses were used for data-validation (e.g. significance testing 
and filtering out of false positives) and detection of abonormal changes (e.g. metabolic 
profiling of diseases).  
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Supplementary Table S1. Experimental conditions for the solid and mobile phase in chromatography 
Precolumn Column Polar Solvent (v/v ratios) Organic Solvent (v/v ratios) Solvent C Additives Year Citation 
Yes T3 C18 1:1 MeOH:H2O (pH 7.5) (PG;PS) 6:4 MeOH:ACN (GP;PS) 
 
AmFo, FoA 2017 [15] 
 
C18 HSS 19:19:2 ACN:MeOH:H2O IPA 
 
AmFo, FoA 2017 [8] 
 
C18 HSS T3 3:4:3 ACN:acetone:IPA (DG;TG) 3:7 ACN:IPA (DG;TG) 
 
AmOH 2017 [15] 
 
C18 BEH 40:60 ACN:H2O 90:10 IPA:ACN 
 
AmAc, AcA 2017 [19] 
 
N/A 40:60 ACN:H2O 90:10 IPA:ACN 
 
AmAc 2017 [18] 
 
C18 50:50 ACN:H2O 95:5 IPA:ACN 
 
AmFo, FoA 2017 [20] 
 
C18 CSH H2O  50:50 IPA:ACN 
 
AmFo, FoA 2017 [11] 
 
C18 60:40  MeOH/H2O 60:40 MeOH:IPA 
 
AmAc, AcA 2017 [7] 
 
C18 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmAc 2017 [22] 
 
C18 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2017 [21] 
 
C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
- 2017 [4] 
 
C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmAc, FoA 2017 [6] 
 
C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmAc 2017 [22] 
 
C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2017 [14] 
 
C18 HSS 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo 2017 [3] 
 
C18 BEH 90:10 ACN:H2O 90:80:1 IPA:ACN:H2O 
 
AmFo, FoA 2017 [17] 
 
C18 BEH* 90:10 H2O:ACN 20:20:60 MeOH:ACN:IPA 
 
AmFo, FoA 2017 [24]* 
 
C18 HSS T3 90:10 IPA:ACN 30:70 H2O:ACN 
 
AmFo 2017 [12] 
 
HILIC, BEH H2O 96:4 ACN:H2O 
 
AmAc 2017 [16] 
 
C8 BEH H2O 2:5 IPA:ACN 
 
AmFo, FoA 2017 [9] 
 
C18 BEH H2O 50:50 IPA:ACN 
 
- 2017 [19] 
 
C18** H2O 60:36:4 IPA:ACN:H2O 
 
AmFo 2017 [23]** 
 
C8 H2O 70:30 ACN:IPA 
 
AmAc, FoA 2017 [2] 
 
C18 BEH H2O ACN 90:10 IPA:ACN FoA 2017 [10]  
C18 HSS T3 H2O ACN 
 
FoA 2017 [13] 
 
C18 BEH H2O MeOH 
 
AmAc 2017 [5] 
*nano-LC, **APCI instead of ESI, ***narrow-bore UHPLC  




Precolumn Column Polar Solvent (v/v ratios) Organic Solvent (v/v ratios) Solvent C Additives Year Citation 
 C18 CSH 40:60 ACN:H2O 90:10 IPA:ACN  AmFo, FoA 2018 [35]  
C18 45:55 ACN:H2O 
  
AcA 2018 [43]  
C18 BEH 60:40 ACN:H2O 81:10:9 IPA:ACN:H2O 
 
AmFo, FoA 2018 [40]  
C18 CSH 60:40 ACN:H2O 90:10 ACN:IPA 
 
AmFo, FoA 2018 [39]  
C18 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo 2018 [33]  
C18 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmAc 2018 [38] 
Yes C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2018 [25]  
C18 HSS 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo 2018 [26] 
Yes C18* 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2018 [45]* 
Yes C18*** 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2018 [45]***  
C8 BEH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmAc 2018 [30]  
C8 BEH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmAc 2018 [30]  
C18 BEH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo 2018 [28]  
C18 BEH 60:40 ACN:H2O 90:8:2 IPA:ACN:H2O 
 
AmFo, FoA 2018 [46] 
Yes C18 BEH* 90:10 H2O:ACN 20:20:60 MeOH:ACN:IPA 
 
AmFo, FoA 2018 [41]* 
Yes C18 BEH* 90:10 H2O:ACN 20:20:60 MeOH:ACN:IPA 
 
AmFo, FoA 2018 [42]*  
C18 SB H2O 90:10 ACN:H2O 
 
AmAc, AcA 2018 [29]  
C18** H2O ACN 
 
FoA 2018 [44]**  
C18 BEH H2O ACN 90:10 IPA:ACN FoA 2018 [32]  
C18 BEH H2O ACN 
 
AcA 2018 [37]  
C18 HSS H2O ACN 
 
FoA 2018 [27]  
Amide H2O MeOH 
 
AmHCO3 2018 [31]  
Amide H2O MeOH 
 
AmFo 2018 [31]  
C18 BEH H2O MeOH 
 
PFPA, FoA 2018 [31]  
C18 BEH H2O MeOH 
 
PFPA, FoA 2018 [31]  
C18 CSH H2O MeOH 
 
FoA 2018 [34]  
C18 HSS H2O MeOH 
 
FoA 2018 [39] 
*nano-LC, **APCI instead of ESI, ***narrow-bore UHPLC  




Precolumn Column Polar Solvent  (v/v ratios) Organic Solvent (v/v ratios) Solvent C Additives Year Citation 
  C18 BEH* 10:90 H2O:ACN 20:20:60 MeOH:ACN:IPA   AmFo, NH3 2019 [71] 
  C18 CSH 40:60 ACN:H2O 90:10 IPA:ACN   AmFo, FoA 2019 [77] 
 
C18 50:50 ACN:H2O 20:80 IPA:MeOH 
 
AmAc 2019 [52] 
  C18 50:50 H2O:ACN 5:95 ACN:IPA   AmFo, FoA 2019 [50] 
 
C18 50:50 H2O:ACN 5:95 ACN:IPA 
 
AmFo, FoA 2019 [57] 
Yes C18 CSH 60:40 ACN:H2O 90:10 ACN:H2O   AmFo, FoA 2019 [55] 
  C18 HSS T3 60:40 ACN:H2O 90:10 ACN:IPA   AmFo, FoA 2019 [60] 
 
C18 CSH 60:40 ACN:H2O 90:10 ACN:IPA 
 
AmFo, FoA 2019 [60] 
Yes C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2019 [66] 
 
C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2019 [74] 
 
C8 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmAc 2019 [56] 
 
C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2019 [65] 
 
C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo 2019 [79] 
  C18 60:40 ACN:H2O 90:10 IPA:ACN   AmFo 2019 [78] 
  C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN   AmFo, FoA 2019 [69] 
 C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN  AmFo 2019 [62] 
 C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN  AmAc 2020 [64] 
  C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN   AmAc 2020 [64] 
Yes C18 BEH 60:40 ACN:H2O 90:8:2 IPA:ACN:H2O   AmFo, FoA 2019 [63] 
Yes C18 CSH 60:40 ACN:H2O 90:9:1 IPA:ACN:H2O   AmFo, FoA 2019 [75] 
Yes C18 CSH 60:40 ACN:H2O 90:9:1 IPA:ACN:H2O   AmFo, FoA 2019 [76] 
 C18 CSH 60:40 H2O:ACN 90:10 IPA:ACN  AmFo, FoA 2019 [58] 
 HILIC 70:30 ACN:H2O 90:10 ACN:acetone  AmFo, FoA 2019 [47] 
  HILIC** 70:30 ACN:H2O 90:10 ACN:acetone   AmFo, FoA 2019 [47]** 
 C18 BEH ACN:H2O IPA:ACN  AmFo 2019 [67] 
  C18 CSH H2O 16:3 ACN:MeOH   AcA 2019 [68] 
*nano-LC, **APCI instead of ESI, ***narrow-bore UHPLC  




Precolumn Column Polar Solvent  (v/v ratios) Organic Solvent (v/v ratios) Solvent C Additives Year Citation 
Yes C8 H2O 55:40:5 ACN:IPA:H2O  AmAc 2019 [68] 
  C18 H2O 75:25 IPA:ACN   AmFo 2019 [59] 
 C18 H2O 75:25 IPA:ACN  AmAc 2019 [59] 
  C18 BEH H2O ACN   FoA 2019 [67] 
  F5 H2O IPA   AmFo, FoA 2019 [51] 
  C18 H2O MeOH   AmAc, FoA 2019 [53] 
 C18 H2O MeOH  AmAc, FoA 2019 [53] 
Yes Phenyl H2O MeOH   AmAc 2019 [49] 
  C8 BEH H2O MeOH   AmFo, FoA 2019 [48] 
 C18 BEH MeOH 2:5 ACN:IPA  AmAc, FoA 2019 [54] 
  C18 HSS N/A N/A   N/A 2019 [61] 
*nano-LC, **APCI instead of ESI, ***narrow-bore UHPLC  
BEH: ethylene bridged hybrid, CSH: charged surface hybrid, HSS: high strength silica, SB: stable bond packing 
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Abbreviations 
ACP acyl carrier protein, AF4 asymmetric flow field flow fractionation, ANOVA analysis of 
variance, AUC area under curve, CARS coherent anti-Stokes Raman scattering, CCS collision 
cross-section, CN total carbon, CRS coherent Raman scattering, DB double bond, DDA data 
dependent acquisition, DESI desorption electrospray ionization, DG diacylglycerol, DIA data 
independent acquisition, DIMS direct infusion MS, FDR false discovery rate, FA fatty acyl, 
FFA free fatty acid, GC gas chromatography, GL glycerolipid, GP glycerophospholipid, HCA 
hierarchical cluster analysis, i.d. internal diameter, IMS ion mobility spectrometry, HPLC 
liquid chromatography, LESA liquid extraction surface analysis, m/z mass-to-charge [ratio], 
LSI Lipidomic Standards Initiative, HR/LRMS high/low resolution mass spectrometry, MSE 
all ions scans, MS/MS tandem mass spectrometry, MS/MS/MS second-generation 
fragmentation mass spectrometry MSn  on-line coupled mass spectrometry system, MSI mass 
spectrometric imaging, m/z mass-to-charge ratio, NP normal phase, NSI nano-electrospray 
ionization,  nESI negative ion mode in electrospray ionization, OPLS-DA orthogonal 
projections to latent structures discriminant analysis, (L)PA (lyso-)phosphatidic acid, (L)PC 
(lyso-)phosphatidylcholine, (L)PE lyso-phosphatidylethanolamine, pESI positive ion mode in 
electrospray ionization, (L)PG (lyso-) phospatidylglycerol, (L)PI (lyso-)phosphatidylinositol, 
NP-HPLC normal phase liquid chromatography, PIS precursor ion scan, PLS-DA partial least 




)phosphatidylserine, QqQ triple quadrupole mass analyzer, QTOF quadrupole - time of flight, 
ROC receiver operating characteristics curve, RP-HPLC reversed phase liquid 
chromatography, RT retention time, SP sphingolipid, SFC supercritical fluid chromatography, 
SWATH sequential window acquisition of all theoretical fragment ion mass spectra, SWARM 
sliding window adduct removal method, TG triacylglycerol, TOF time of flight mass analyzer, 
UHPLC ultra-high performance liquid chromatography, VIP variable importance projection 
1. Introduction 
Recent lipid research has emerged due to improved multidimensional computer algorithms and 
highly efficient commercial, open-source and in-house software platforms. Furthermore, data 
libraries for automated routine searching of mass spectra is adopted for lipid identification. 
International organizations have started together to harmonize knowledge about lipidomics. 
Especially, the Lipidomics Standard Initiative (LSI, https://lipidomics-standards-
initiative.org/) found under the International Lipidomic Society 
(https://lipidomicssociety.org/about/) and Lipid Home (https://www.lipidhome.co.uk/) strive 
to standardize lipidomic information with the globally acknowledged platform Lipid MAPS 
(https://www.lipidmaps.org/). Furthermore, Sumner et al. [1] have stated minimal requirements 
for retraceable lipid analyses, [1] which are important for integrated research in lipidomics. 
This review on lipid investigatios encompasses research conducted with ultra-high 
performance mass spectrometry (UHPLC-MS) during 2017-2019 [2-79]. To clarify, this 
review uses the term high performance liquid chromatography (HPLC) to describe both 
conventional HPLC and UHPLC. However, blindspots of exclusive UHPLC-research are 
attempted to be covered in the Discussion-section.  
Particularly, half of the reviewed studies deal with computerized platforms to identify lipid 
species of several classes. These computerized platforms have successfully enabled data 




all, the most popular means of comprehensive identification in -omics research is on-line 
coupled mass spectrometry systems (MSn, e.g. tandem mass spectrometry [MS/MS]), which 
demand extensive and thorough data-handling. In the field of lipidomics, MSn is often divided 
into data-dependent acquisition (DDA) and data-independent acquisition (DIA). Here, DDA is 
typically defined as fragmentation of only targeted precursors, as is the case in parallel reaction 
monitoring (PRM) [15], [44], [45]. It is a technique, in which all fragments of the chosen lipid 
precursors are measured. In DIA, all available lipid precursors are fragmented and measured 
in a full scan with a set of collision energy (CE) or energies, detecting a substantial amount of 
lipid adducts fragmentation patterns, e.g. in an all ions scan (MSE) [9-15], [32-34], [55-61], 
[68], [74]. 
Recent DIA research were applied in a novel MS technique called sequential window 
acquisition of all theoretical fragment ions spectra (SWATH MS) [6], [44], [73-76] and 
similarly, with QTOF-specific SONAR technology [69]. The consecutive fragmentation or 
scan of precursors (i.e. PRM for DDA and SWATH or SONAR for DIA) and their product ions 
provide cleaner MS spectra in favour of library searches, an improved detection rate, broadened 
range, and expanded specificity in any given fragmentation frame compared to other methods 
[34], [44], [73], [69]. Different MS and MS/MS techniques are compiled in Table 1. When 
significant, instrumental and experimental conditions for glycero-, glycerophospho- and 
sphingolipids are focused on and referred to [80-88]. 
2 Fatty acids, lipids and metabolites of the survey 
Fatty acids are synthetized in cells and their cell membranes, endoplasmatic reticulum, Golgi 
apparatus, and mitochondria [89], [90]. Most lipids are products of free fatty acids in presence 
of coenzyme A and NADPH [91]. This literature survey deals with a short area of lipidomics 
and contains commonly studied lipids, e.g. glycerolipids (GLs) like mono- (MG), di- (diacyl-, 




lipids in analytics, Figure 1 illustrates the functionalities of TG lipids. Glycerophospholipids 
(GPs) from GLs are also included, since they are frequently detected like the most abundant 
lipids in eukaryotic cells, i.e. phosphatidylcholine (PC) and phosphatidylethanolamine (PE) 
[92]. Other GPs dealt in this review include phosphatidic acid (PA), phosphatidylserine (PS), 
phosphatidylinositol (PI), phosphatidylglycerols (PGs), and PG-derived cardiolipins (CLs). 
[92] To observe the challenges of separation and identification issues some glycerolipids and 
glycerophospholipids are illustrated in Figure 2.  
GPs may appear with fatty acids which both are bound with ester or ether groups, the latter 
being defined as plasmalogens (PLs) [92]. PLs are detected and identified either by an alkenyl 
linker with an oxygen (e.g. PI[O-18:0/17:0]) or with a phosphorous (e.g. PI[P-18:0/17:0]) [92]. 
Those structural hetero atoms help mass spectrometric detection, although there may not be 
improvements in chromatographic separation.  
An interesting group of surveyed lipids is sphingolipids (SPs, Figure 3, [28]). They have a 
basic backbone with various kinds of lipids. The backbone is formed from serine amino acid 
and a long-chain fatty acyl catalyzed by coenzyme A in mammals [92]. The analytics is focused 
to ceramides (Cer), which have amine-bonds with fatty acids.  To sum up, interest is focused 
on esterified fatty acids with glycerol head groups (glycerolipids, glycerophospholipids) or a 
sphingosine headgroup (sphingolipids), but not a sugar backbone (saccharolipids, a topic of 
worth its own review). Other groups left out are defined by characteristic hydrocarbon 
structures, i.e. fatty acyls, prenol lipids, sterols and polyketides [94]. More analysis on lipid 
classes and metabolism is discussed elsewhere [101]  
3 Instrumentation 
In lipidomics, a wide range of articles introduce new or improved methods which are validated 
with UHPLC-MS, capillary-UHPLC-MS (nUHPLC-MS or nano-UHPLC-MS) instruments 




development of chromatographic methods [9], [22], [27], [45], MS/MS identification [7], [16], 
[23], [27], computational methods for improvement of measurement performance [17], and 
data analysis [21], [25], [96]. Recent challenges in HPLC-MS seem to be fluctuation 
(repeatability) of analysis [97], [98] results, which hinder reliable identification and inter-
laboratory tests of lipids. Since in chromatographic environments elution of different lipid 
types and their species may differ [98], deconvolution of data via manual or computational 
analysis may be the only reasonable compromise. 
The reviewed papers show that all lipid analyses have fluctuation of lipid composition and 
intensity based on the fingerprint profiles of different biological matrices. These observations 
can be explained by distinctive matrix effects, which in turn inform that there is a specific need 
of sample preparation before analyses. Usually, lipidome studies are done with simplified 
sample preparation to avoid recovery losses in clean-up steps. [99] Mostly, the clean-up steps 
are protein precipitation and extraction of solid matrix compounds (e.g. biological tissues) and 
fluids (e.g. plasma, serum, lavages, cell suspensions and supernatants).[99] Furthermore, solid 
materials may trap internal standards and analytes, which increases variation of results in 
quantification and leads to less accuracy and precision of the methods. [100] Sample 
preparation of biological and clinical samples is discussed more elsewhere [101].  
Though reconstitution with the most used polar acetonitrile - water mixture (60:40, v/v) and 
organic isopropanol - acetonitrile (90:10, v/v) eluents is practical, none of these dissolve lipids 
comprehensively. For instance, acetonitrile - water at 60:40 (v/v) recovers STs and TGs 
incompletely. [45] Furthermore, Danne-Rasche et al. [45] observed a distortion or even loss of 
lipids with i-propanol - acetonitrile mixture (9:1, v/v),  when the eluent was used in nano-
UHPLC. Thus, lipids need to  be reconstituted into a standardized mixture such as butanol - i-
propanol - water (8:23:69, v/v/v) [45] prior to injection. The solvent composition is important 




sample preparation, all lipid samples need to be dried for getting concentrates of HPLC-MS 
research. Furthermore, concentrates are needed to measure multidimensional MS spectra to 
obtain accurate identification and algorithm-based data handling of features.  
To reduce systematic noise and other disadvantages (e.g. adsorption, peak broadening, adduct 
formation) in chromatographic data has been attempted via computational methods, i.e. with 
the sliding window adduct removal method (SWARM). [102] SWARM is based on the 
systematic interference caused by multiple adduct ions of the same analyte. The interference 
induces systematic noise patterns that may be excluded to enhance accurate mass acquisition 
for metabolites. Then, the adduct signal overlap correction for low-to-moderate resolution mass 
spectra could be utilized. 
Modern instrumental separation and detection methodologies are still on-going needed to avoid 
frequent appearance of false negative lipid identifications and to establish sufficiently reliable 
and label-free (i.e. standard-free) methods. Identification of lipids showed to be improved by 
multiply usability of analytical variables and by using more independent properties, such as 
chromatographic retention times (RT) and mass spectrometric mass-to-charge ratios (m/z) of 
lipid ions/adducts, fragmentation/isotope patterns, and collision reactions. Reliability for 
targeted lipid species identified by internal standards and calibrants have made lipid analyses 
possible in quite many case, but especially non-targeted lipid analyses demand the super power 
and speed of computers with algorithm-based libraries.[96], [103], [104] Thus, the analyses 
can be independently conducted without potent analytes. Evidently, the computerized methods 
have utilized automated systems when internal standards for normalization are neglected. [2], 
[3], [10], [11], [13], [14], [16], [17], [20], [21], [22], [24], [26], [30], [32-36], [38], [44], [4 6], 





HPLC techniques are preferred for their ability to enhance identification by predictable 
retention time patterns [98], [105] and reduced mass ambiguity [106]. In lipid research, the 
sub-method UHPLC is preferred over HPLC due to its lower dispersion, substantial decrease 
in solvent usage, shorter analysis times without compromising resolution, higher resolution 
performance due to smaller (sub-2 µm) fully porous particles or (sub-3 µm) core-shell material 
[73] in columns (enabled by higher pressure capabilities) and enhanced retention precision. 
[107] 
Our dataset [2-79], [108] informs current lipidomic UHPLC-MS separations to be primarily 
done with additive-assisted reversed phase liquid chromatography (RP-HPLC) hyphenated 
with separate experiments on positive electrospray ionization (pESI) and negative electrospray 
ionization (nESI). Though ESI was predominantly used for UHPLC-MS, some atmospheric 
pressure chemical ionization (APCI) studies were also conducted. [23], [44], [47]. ESI as a 
‘soft’ and APCI as a ‘hard’ ionization technique, respectively, are suitable for supporting lipid 
identification. [23] In respect of that, Beccaria et al. [23] developed a method suitable for both 
detection approaches with no need to change HPLC parameters.  
Elution of lipids in HPLC is done in many elution models (e.g. isocratic elution, curved 
gradient following an exponential or logarithmic function, stepped gradient, linear gradient, 
etc.). The suitable stationary and mobile phases with methods are also found in Table 1. More 
detailed information on stationary and mobile phases as well as lipid adduct concentrations is 
in Supplementary (Table S1). 
3.1.1 Reversed phase separation in HPLC 
In lipidomics the commonly used RP-HPLC separation methods are based on the interaction 
of a nonpolar stationary phase with nonpolar lipid analytes. Nonlinear or second-degree curves 
between the retention times and total carbon (CN) double bonds (DB) are used for quantitative 




adducts from similar exact masses (e.g. [PC(38:4)+Na]+ and [PC(40:7)+H]+ [9]). However, 
retention time prediction can be complicated due to pH dependent speciation [109], 
experimentally made validation and multi-step liquid gradients [23].  Separation of polar 
components (i.e. early retaining lipids) can be affected by the mobile phase gradient. When 
elution is started with high percentage of organic mixture, polar compounds are longer 
adsorbed and retained on RP-HPLC phases. [110] However, changes of eluent polarity are 
interlinked with the ionization rate of polar lipids, which in turn can have an impact on elution. 
[110] RP-HPLC with polar solvents (i.e. non-aqueous RP-HPLC) is enabled by polymer-based 
columns which are end-capped by a methyl or hydrogen group. [110] Some column materials 
are based on modified silica, which when not shielded are short-periodically used with water 
modified organic solvents due to free silanol groups having the attractive functions. [110] 
In contrast to phenomena in reversed phases, normal phases in HPLC (NP-HPLC) typically 
separates analytes containing polar  functionalities having silanol, amino- or diol groups. [111] 
NP-HPLC is excluded from the review, since only a single article on NP-HPLC with amide 
column was observed during 2017-2019 on lipid separation [31]. 
Since even the variation among lipid class species can be substantial, it is not surprising that 
the polarity of their classes varies a lot. Tumanov and Kamphorst [85] (Figure 4) demonstrated 
the lipid-subclass range of four distinct chromatographic approaches, which are divided to two 
groups (one a RP, one a NP separation strategy in each group). The subclasses in (A) include 
lipids of the nonpolar kind, whereas the separations of (B) are modelled to the polar lipid 
subclasses. Particularly, polar (lyso-forms, MGs, sphingosine-related compounds, FAs, acyl 
carnitines and acetyl coenzyme A) and mid-polar (PS, PG, PI, Cer) lipids seem to be species 
often analysed with the negative ionization mode, though more species are primarily found 
with positive ionization. From the GLs only MGs have FA chains with 16 counts, i.e. they are 




they have amide-bound FA chains. [85] Thus for reliable research data, accurate UHPLC-MS 
methods are needed to identify the individual lipid class species.  
3.1.2 HILIC 
Essentially, hydrophilic interaction liquid chromatography (HILIC) columns are micro-bore 
columns with stationary phases of mixed hydrophilic interactions for nonpolar compounds and 
hydrophobic interactions for polar compounds. However, nonpolar lipids (e.g. CEs, TGs) and 
lipids with only one hydroxyl group (e.g. Cer, DG, MG, and cholesterol) are often barely 
retained. [16] Nevertheless, HILIC is a well-established subclass of NP chromatography that 
allows usage of water as the eluent (5-40%, >2% needed) as in contrast to conventional NP. 
[112] HILIC platforms are ideal for quantitation, since lipid class species co-elute with their 
respective calibrants. [109]  
PAs and PSs species are known to have broad or barely detectable peaks in RP-HPLC, thus, 
HILIC is used. [112] Furthermore, as PAs and LPAs co-elute among major lipid components 
(e.g. PCs, PEs, SMs) in RP-HPLC. Because of that the comparatively lower abundance of lipids 
in this class, PAs and LPAs have no selective fragment to differentiate from other lipid classes. 
Thus, proper methods for PA/LPA separation have been specifically approached with HILIC. 
[113], [109]  
Though being a well-established technique for HPLC-MS quantitation, not many UHPLC 
analyses have used HILIC-columns for separation. [16], [47] Thus, HILIC applications are also 
excluded from the scope of this review. 
3.1.3 Nano-UHPLC 
In nano-HPLC [112] columns of sub-millimetre internal diameter (i.d.) are filled with 
conventional column packing materials. Published papers [41], [71], [24], [45], [42] inform 
only about using a loaded capillary (i.d.: 1-0.001 mm [114]) or a nanobore column (i.d.: 0.1-




smallest possible narrow bore columns (2.1-4 mm). Surprisingly, along with nano-HPLC a 
low-resolution triple-quadrupole mass spectrometer was unequivocally preferred.  
In contrast to a faster UHPLC separation, in nano-HPLC the “loading time” followed by the 
sample elution was extended due to the low flow rate restrictions (0.3-0.35 μl/min). [71]  
Nano-HPLC methods show a great capacity for lipid identification with a low-resolution mass 
analyser, since then both an extremely broad identification range and high sensitivity at the low 
fmol-scale are gained using a low throughput (analysis time: 40-60 min). [41], [45] The result 
was that the low fmol range for almost every GLs, GPs, SPs and their lipid derivatives was 
reached in the positive ionization electrospray mode (pESI). For example, the calibration curve 
for a specific PE (17:0/14:1) demonstrated a linear relationship between 16-10000 fmol by 
pESI-MS detection and 0.64-2000 fmol by nESI-MS detection [41] By contrast, with HPLC-
ESI-MS the linear dynamic range for the same analyte reached around 80-10000 fmol by pESI-
MS and 16-2000 fmol by nESI-MS. [45] Similarly, Kim et al. [115] achieved a LOD-range 
from 59 fmol (LPC(17:0)) to 507 fmol (LPG(14:0)) with untargeted nano-UHPLC-ESI-
MS/MS of lipoprotein by pESI and nESI ionization, respectively. [115] 
3.1.4 Mobile phases in hyphenation of HPLC with MS 
Mobile phases in HPLC are usually modified to help in lipid detection and their separation with 
HPLC. [112] As the sensitivity issues are concerned, composition of eluents is important to 
obtain stabile adduct ions in MS. [23] Volatile buffers (e.g. formic acid, acetic acid, or their 
ammonium salts [116]) are used in lipidomics methods. [113] However, earlier studies report 
lipid results with 5 µM phosphate buffer (nanoelectrospray ionization) [9] and 5 mM 
phosphoric acid [45]  
In some cases, additives in HPLC eluents may cause analytes to become undetectable due to 
signal suppression. Cajka and Fiehn [117] studied the effects of five different modifiers in both 




(BEH) particles and the slightly better charged surface hybrid (CSH) particles. [117] Whereas 
the experiments could be concluded by choosing the optimal mobile phase modifier to be 
formic acid or formic acid/ammonium acetate for pESI and ammonium acetate for nESI. Using 
a CSH C18 column with HPLC-pESI-MS studies Monnin et al. [118] reported about a further 
enhanced ionization efficiency by choosing 0.02% acetic acid as the additive in eluent. 
Whereas the signal for LPLs (except LSM) and GPs certainly increased by manifold, Cer and 
PCs experienced a decrease in peak area when compared with analyses data with 10 mM 
ammonium acetate. [118] However, specific to PCs their carbonate ion adducts showed 20-
fold stronger signals compared to their ammonium adducts with CID-MS/MS. [119] 
3.2 Importance of mass spectrometry detection in lipid research 
Formation of adducts is dependent on the molecular structure and functional groups of a lipid 
(e.g. deprotonation of carboxyl groups in fatty acid with nESI). Lists of exact masses in MS 
and MS/MS, non-protonated adducts, possible collision energies and lipid classes/topics are 
listed in Table 3. Furthermore, sources like Lipid maps providing a free MS/MS prediction 
tool (http://lipidmaps.org/resources/tools/index.php) and a structure database library 
(http://lipidmaps.org/data/classification/LM_classification_exp.php) allow data handling in 
lipidomics. 
MS advancements, such as a quadrupole Orbitrap mass analyzer (Q-Orbitrap) [9], [17], [20], 
[22], [27], [31], [46], [49], [51], [55], [56], [62-65], [77], [79], and NSI [24], [45], [71] have 
extremely increased resolution capabilities (theoretical plate number in HPLC >35 000 /m) for 
lipid identification. However, compromises need to be done before the analyses, since either 
mass accuracy or ion resolution is emphasized depending on whether identification or 
quantitation is preferred. Furthermore, identification is improved with the help of orthogonal 
measurements, such as collisional cross-section (CCS) values with ion mobility spectrometry 




flight (QTOF) [6], [16], [25], [68]. Furthermore, the inclusion of trapped IMS (TIMS) 
combined with parallel accumulation serial fragmentation (PASEF) has emerged to enhance 
complementary MS/MS and IMS data. [126] 
For high-resolution MS, an Orbitrap [2], [5], [34], QTOF [4], [6], [10-16], [21], [25], [28], 
[30], [32], [33], [36-40], [43], [44], [53], [54], [59-61], [66], [68-71], [71], AA073, [74], [75], 
AA076, [78] and QOrbitrap [3], [5], [9], [17-20], [22],  [26],  [27],  [31], [34], [35], [46], [47], 
[49-51], [55-58], [60], [62-65], [72], [77], [79] were used. However, some studies settled for 
low-resolution MS, mostly with a triple quadrupole instrument [7], [8], [23], [24], [30], [41-
43]. Most rarely, pseudotargeted methods [21], [30], [54] (i.e. lipid identification with an in 
silico library), polarity switching [5], [17], [23], [41], [49], standalone nESI mode in MS [29], 
[43], [68], NSI [45], [71] and atmospheric pressure chemical ionization (APCI) [23], [44], [47] 
were used.  
3.3 Data acquisition and processing 
Identification and determination of lipids and their metabolites need commercial, open-source, 
and sophisticated tailor-made tools [127]. The statistical tools, analysis software, and 
algorithms enable visualization and perceiving of patterns from large datasets and raw data 
[103]. Metabolic profiling of MS data is done with multi-variant programs, such as 
Metaboanalyst, [10], [11], [17], [27], [32], [34], [37], [40], [46], [59], [63], [77] or MeV [3], 
[30], [65], [61], [79], [103],. All in all, reported software environments for data processing 
constitute mostly of R and SPSS languages.  
Manual programming from the ground up or with borrowed code demands more computational 
expertise. Koelmel et al. [96] compared identification algorithms with the commercial R-based 
LipidMatch-tool, which is tailored for lipid identification softwares. [96] For a deeper 




automated workflow for rule-based lipid identification using untargeted high-resolution 
tandem mass spectrometry data“ gives excellent information [96].  
4 Analysis 
4.1 Identification of lipids  
Lipid identification can be enhanced by using information about the individual lipid itself, e.g. 
by increasing orthogonal information via “polarity switching” [5], [17], [23], [41], [49] instead 
of only using one ionization mode in the measurements or by the introduction of supporting 
measurements or (lipid class) expanding methods. Identification demands are partly already 
mentioned in Introduction and chapters, where chromatographic parameters are discussed 
referenced to resolution and sensitivity. 
In lipid studies, absolute retention time (RT) variation during sample analyses is easily 
increased by small differences in experimental conditions (preparatory, chromatographic, and 
instrumental parameters). However, more repeatable separation techniques along with feature 
alignment enables more reliable identification with RTs in inter-laboratory studies in the future. 
[128] Since measurements of m/z ratio are significantly less deviant (parameters affecting m/z: 
ionization efficiency and mass spectrometric setup), single m/z, feature, and low-resolution 
spectra matching are the most used means for quick identification. [7] If needed, high 
resolution precursor and product ion spectra are usually obtained to achieve accurate 
identification between highly similar species. For further optimization of mass spectrometric 
identification, adduct formation and control of collision energy should also be studied and used. 
It is commonly agreed that adduct ions are formed mostly during ionization [9], [73], which is 
why lipid species appear at the same retention time in both pESI-MS and nESI-MS. Apart from 
protonated and deprotonated species, adding of millimolar concentrations of salts can be 
harnessed for signal enhancement [129]. Though at too high concentrations lipid signals can 




ions are acetate (CH3COO
-) [56], [68], formate (HCOO-) [48], [50], [57], [58], [60], [75-77], 
and ammonium (NH4
+) [48], [50], [56-58], [60], [74-76]. Sodium (Na+) and potassium (K+) 
adducts are also commonly observed, though no controlled addition of such salts was noticed 
[92]. 
High resolution RP-HPLC separates structural isomers of lipid classes, [9] up to the point of 
carbon chain regioisomers (i.e. sn-positions of lipids). However, comprehensive identification 
of isobars and isomers could not be achieved by solely using MS/MS. For example, Lisa et al. 
[16] and Blaženović et al. [25] reported unresolved isomers and isobars with identical CNs and 
DBs but different fatty acyl composition. Adducts with same nominal mass can be separated 
with MS/MS [23], but specific information like sn-position of DBs needs other methods, like 
derivatizing of free fatty acids to form 4-iodobenzyl esters [130]. The reaction is made to 
esterified fatty acids into distinguishable epoxides via  ketone dioxide catalyst and oxidant 
[131] or to oxetane-adducts via the Paternó-Büchi photochemical reaction. [132], [133], [134] 
Mass spectrometric solutions include second-generation fragmentation (MS/MS/MS) by dual 
stage collision-induced dissociation (CID) [135] or CID and ozone-induced dissociation 
combined, or silver-ion chromatography (currently achieved only with TGs) [81], [112], [136]. 
Recently, Zhao et al. [119] also mentioned electron impact excitation of ions from organics 
(EIEIO) and photo-ultraviolet dissociation (PUVD, photodissociation [130]) in the list of non-
CID methods for sn and DB position.  Since lyso-forms of GPs, i.e. sn-2 acyl lipids retain less 
in a HPLC column than their sn-1 isomers, they can be identified as separated double peaks. 
[9]  
4.2 Quantification of lipids 
Burla et al. [99] (a statement of the global lipidome community) compiled guideline 
recommendations for quantitative analysis in clinical sample matrices, specifically absolute 




quantification results, lipid concentrations should be reported in the SI-units mol/L or molar 
percentages whenever possible. [99] 
In comparison to lipid identification, quantitative analysis is increasingly dependent on control 
samples as well as the quality and concentration of included standards, i.e. internal standards 
and calibrants. Common control samples include blanks and quality control (QC): Blanks are 
included for standard impurity monitoring and validation purposes, whereas QC samples (a 
pooled sample of all study samples in a batch) serves to monitor and correct batch-related 
uncertainty, instrumental errors and evaluate the performance of lipid analytes for validation 
purposes. [99]  
Absolute quantitative calibration of lipids is either conducted via spiked QC samples (surrogate 
calibration) or by direct introduction of standards in the study sample as is often done in single-
point and standard addition calibration. [75] However, single-point calibrations are reported to 
overestimate target lipid concentrations due to inherent flaws in the regression. [75] An ideal 
calibrant for complex matrices has an identical response factor, ionization efficiency and 
experiences comparable matrix effects as the analyte. [137]  
For better understanding quantitative UHPLC-MS, some differences between HPLC-MS and 
DIMS should be pointed out. Though DIMS is more robust at the high-concentration lipids 
(µmol/L-mmol/L) of a sample, HPLC-MS is advantageous for the identification and 
quantification of low- and very low-abundance lipids (<nmol/L-mmol/L). [137], [99] Anyway, 
lipid class coverage and sensitivity are considerably improved in HPLC-MS experiments. [99] 
As an inherent disadvantage in HPLC-MS, the risk of lipid-lipid interaction increases due to 
the enrichment of same lipid species occurring in the column, though hetero-interaction 
between different lipid species decreases. [137] HPLC-MS uses peak areas in contrast to 




Moreover, the fluctuating quality and quantity of molecular species in the ion source is a 
recurring problem for lipid quantifications. These issues are amplified by the increasing 
complexity of experimental setups, such as chromatographic gradients affecting electrical 
properties (i.e. ionization efficiency) of the eluent. This has implications not only for the 
ionization efficiency, but also for the MS instrument’s response factor: alongside solvent 
composition, Drotleff et al. [75] reports post-acquisition MSn procedures like SWATH or 
multiple reaction monitoring (MRM) to further deviate the detector’s response values from one 
unit per molecule. Drotleff et al. [75] proposed “post-acquisition recalibration” as a reasonable 
compromise, if not enough sample is available for using the standard addition method. Then, 
sensitivities of analytes can be determined via a certified reference material. For lipids, only 
the NIST CRM 1950 plasma reference is currently acknowledged. [75] Standard mixtures, such 
as the Splash® Lipidomix® mixture (Avanti Polar Lipids Inc., Alabaster, AL, USA) have been 
used for mimicking corresponding lipid concentrations in experiments as in biological fluids, 
e.g. human plasma, and for normalization of the analyses [14], [28], [66]. Since lipidome 
isotope labelling of yeast (LILY, complete lipidome carbon labelling with C13 isotope [138]) 
technology is discovered very recently, studies on using it in practice could not be considered 
in this review. 
Furthermore, solvent-system dependent lipid concentrations of >10-100 mmol/L are reported 
to form significant amounts of poorly ionic lipid aggregates (results found in a DIMS 
experiment). [137] The formation of aggregates like dimer, oligomer and micellar structures is 
further increased by the hydrophobicity of the lipid analyte and polarity of the mobile phase. 
[137]  
Biological matrices include inherent variation in concentrations. UHPLC-MS experiments 
mostly revolve relative quantification and study changes in the lipidome of biological systems. 




quantification of targeted lipids. [99] Main limitations of absolute quantification in HPLC-MS 
concern ambiguities preceding calibration, i.e. the structural versatility of lipid species, lipid 
concentrations at the lower (or upper) border of their linearity range, and various matrix effects 
such as ion suppression and enhancement. [99] Whereas polar lipid species quantification 
reaches a ~5% accuracy (due to the polar headgroup predominantly explains their MS 
sensitivity) [137]. Mid- to nonpolar lipids like TGs and cholesteric esters are more effected by 
their specific structure in ESI-MS. [104] Thus, these lipids need more attention in standard 
representation. More details on quantitative and validation in lipid analyses are informed in 
Refs. [99] and [104].  
5 Data analysis of lipids 
According to the lipidome community, experimentally acquired raw data should be available 
for result-validation purposes and study re-analysis, whereas analytical details and results 
should be included in a file with acknowledged “XML[-based] or structured tabular format”. 
[99] Corresponding raw data information can be taken from the proteomic field, which has 
practical formats for efficient data sharing. [99] 
5.1 Normalization 
Normalization of raw data is used to reduce systematic fluctuation concerning an accurate 
measurement. For example, Boysen et al. [139] developed the best matched internal standard 
normalization (B-MIS), an algorithm-driven solution for correcting non-biological variation of 
raw data (i.e. ion suppression by matrix effects, chromatographic quality and analytical drift). 
Obscuring variation, i.e. changes of peak area as a function of concentration, is compared 
between an unrestricted set of internal standards and analyte peaks in a QC sample. As a result, 
the algorithm chooses a suitable standard for normalization if the relative standard deviation of 
the peak area is improved by 40%. [139] Furthermore, Drotleff et al. [76] considered B-MIS 




variation, median absolute deviation and variance. His team observed a small difference in real 
positives favouring this normalization, but also noted that normalization models may work in 
a complementary fashion with their respective strengths and weaknesses. [76] Though not yet 
applied in absolute quantification experiments, B-MIS appears as a good alternative for model-
based peak area normalization in relative quantification methods. [139], [76]  
Normalization is done with single standards representing the whole range of lipid classes. 
Suitable internal calibration standards with the same head groups and similar, but not identical 
fatty acids (e.g. odd-numbered <1% abundant in higher organisms [104]), or isotope-labeled 
fatty acids are preferred for normalization [104]. The most used internal standards are 
deuterated at the carbon chain of their FA end to have either 7 or 9 deuterium atoms. [75] 
Internal standards included in QC samples are used for post-correction of systematic errors (i.e. 
drift and other batch-biases) [104], [99] like changes in peak shapes influencing the peak areas 
and for monitoring carry over [112].  
5.2 Data libraries  
Typically, lipid metabolite features in untargeted analyses are compared to available library 
spectra. [66], [118] Therefore, acquired data is represented by a “closest-match” for the m/z or 
total ion spectrum that is compared, typically accompanied by a score from 1-100%. Evidently, 
this approach may lead to false positive results, when the database used is incomplete or when 
the reference data is noisy [128]. 
Along with home-made databases [30], [32], [33], [36], [51], [54], [68], [78], commercial and 
open-source libraries have gained popularity and variety both for monitoring the lipid range 
with MS by characterizing fragmentation patterns for selective identity searching of lipids. 
Information about individual libraries and their respective types are compiled in Table 4. 
Specific tools like open-source softwares are mentioned in Table 5, whereas chemometric and 




from the LSI document (https://lipidomics-standards-initiative.org/links) and LIPID MAPS 
pages (http://lipidmaps.org/resources/tools/index.php). 
5.3 Chemometric tools 
Typically, metabolic correlation and significance analyses of lipids is conducted with a set of 
visual chemometric analyses and statistical methods. Chemometric methods provide an 
overview on analyte trends and outliers in relationship to their observations (features, spectra, 
etc.) with principal component analysis (PCA) [5], [7], [13], [16], [17-19], [27], [30], [31], [33-
36], [38-40], [43], [47-49], [51], [52], [54], [56-60], [62-64], [66], [68], [69], [72], [73], [75-
79], [124], systematic but hidden/uncorrelated variation between lipidome states with partial 
least-squares regression – discriminant analysis (PLS-DA) [3], [7], [10], [11], [26], [32], [34], 
[35], [48], [59], [60], [64], [76], [79], or orthogonal projection of latent structures – 
discriminant analysis (OPLS-DA) [4], [6], [9], [19], [27], [33], [36], [37], [49], [50], [52], [54], 
[57], [60], [69], [78], [79], (relative or exact) concentration evaluation with boxplots [10], [18], 
[19], [32], [34], [37], [40], [44], [45], [48], [58], [60], [61], [67], [69], [73], [76] or a heatmap 
[3], [5], [7], [10], [11], [17], [26-28], [30-32], [34-38], [40-42], [45], [47], [48], [52], [56-58], 
[62], [68], [69], [73], [77], [79] visualizations for significant outlier detection such as the 
Bland-Altman plot [16], [40], [43-45], [55], analyte interaction or metabolic interlinkage of 
lipid species via hierarchical cluster analysis (HCA, often included with heatmap analysis) [3], 
[5], [7], [10], [17], [26], [27], [34], [37], [39], [40], [47-49], [68], [69], [73], [77], [79], 
interactive network [3], [26], [47] or pathway analysis [3], [7], [11], [26], [27], [37], [60], and 
diagnostic tools such as importance testing of PLS-DA variables  with variable importance 
projection (VIP) [3], [10], [26], [33-37], [48], [50], [52], [57], [64], [79], OPLS-DA variable 
reliability and importance evaluation via S-plots [6], [27], [50], [57], [69], [79] or volcano plots 
[11], [31], [41], [42], [48], [60], [63], [67], [74], [77], [78], and method or sample comparisons 




PCA [140] pursues to flatten a large dataset with multiple variables to find the most important 
two sources of variation, i.e. principal components. This is done by comparing the transitions 
between all variables and flattening them into two dimensions with matrix operations. Thus, 
the most important information about multivariate data is found. This reduction process may 
help to divide the studied compounds into different groups and characterize them. [141] 
Similarly, PLS-DA seeks to flatten multivariate data to find the most fitting parallel two-
dimensional plane representing the whole dataset, [140] whereas OPLS-DA reduces the dataset 
to an orthogonal plane found with the partial least square plateau of the dataset. [142] Briefly, 
HCA clusters and categorizes sample components according to their apparent covariant 
relationship. [143]  
Before actual multivariate data-analysis, the data needs often to be transformed, i.e. cleaned, 
scaled and re-centered, as is often done with e.g. statistical noise corrections or discarding of 
noisy data/spectra/outliers, unit variance or Pareto scaling and mean centering for PCA. [144] 
Chemometric methods, such as PCA, PLS-DA and OPLS-DA have kept their positions as the 
most common tools for visualizing analyte groupings (PCA) and metabolic changes (PLS-DA, 
OPLS-DA). Furthermore, VIP has emerged as an emphasis estimator of PLS-DA variables [3], 
[8], [26], [32], [34], [37], [64], [79] emphasizing the importance (i.e. magnitude) of each 
variable. In this context, lipids in the projection plot with VIP scores >1 are most accountable 
to predict changes in metabolism. More extensive analyses can be found in Ref. [88] 
5.4 Statistical tools 
In lipidomic research, statistical methods have developed into a broad variety of numerical tests 
and visualization techniques. Targeted and untargeted methods are two distinctively different 
approaches, as well as the means of data processing. Gorrochategui et al. [103] divided the 
targeted processing of metabolites into five phases: (1) the acquisition of raw data, (2) the 




analytes, (3) the pre-processing and identification of these metabolites, (4) the normalization 
and quantification of the identified species, and (5) the reflection of the results on the 
biochemical/physiological context of metabolic pathways. [103] In contrast to targeted 
approaches, untargeted approaches need more careful experimental MS data processing, data 
modification, and evaluation for pre-processing to attain sufficient data quality. By this way, 
relevant biomarkers can be identified from the totality of detected features/peaks. The data 
quality is directly affected by the sensitivity and resolving power of the applied 
instrumentation. The non-targeted steps include the same pathway elucidation as in the targeted 
analyses, however, with respective appropriate tools. [103] 
Statistical methods include a null hypothesis to test similarities by using one dataset. However, 
the p-value parameter in the Student’s t-test [2],  [10], [14], [15], [18], [19], [26], [27], [32], 
[37-39], [42], [50], [52], [54], [56], [57], [60], [61], [63], [67], [72], [79],  the non-parametric 
Mann-Whitney U-test, [15], [31], [35], [41], [50], [57], [58], [74], [77], and the analysis of 
variance test (ANOVA) [2], [7], [10], [17], [22], [27], [32], [33], [46], [64], [69], [79] are for 
comparison of two or more datasets. These methods are often used for validation of analytical 
data and for detection of changes (e.g. analyte concentrations) between a control sample and 
authentic samples. Together with statistical tests, correction methods such as the Benjamini-
Hochberg test [145] are used to calculate the false discovery rate (FDR), i.e. minimizing false 
positive data in the dataset [56-58], [60], [74], [76]. 
The t-test designed for comparing two independent variables (e.g. patient versus control group 
lipidome data and that before and after drug intake) may be unreliable, when the sample size 
number is small (n<30) or when other kinds than normal distributions arise through the data 
processing [63]. This is the case for most sample number described in the articles reviewed for 
this paper. The average number of real samples studied was around 10-20 with the excluded 




clear split of 7-16 and ~30 in the number of controls used in the individual studies [30], [34]. 
Some cases of statistical testing of the datasets may be questionable, since e.g. t-tests were not 
reliable, when variances between populations were different.  [146] For these kinds of cases, 
an unequal variance test like the Storey [74], [115] or Welch [48] t-test may be used instead 
[48], [74].    
The Mann-Whitney U-test [147] (also known as the Wilcoxon rank-sum test) is used in 
mathematical data handling, when there are not any fixed parameters, which can be used to 
evaluate similarities of two independent dataset medians with a null hypothesis. For two sets 
with same or different sample sizes, the values of both datasets are sorted from the smallest to 
the largest one. The ranking integer is divided, if two values are identical: for instance, when 
two datapoints have the value 2, they will be both noted as 1.5 [147]. Then, the separately 
ranked sample value sets are individually summed. When any of the sums reaches the critical 
value range of the U-test, the null hypothesis can be rejected.  Akin to the Student´s t-test [63], 
the U-test is evaluated by determining the z-score (𝑧 =
𝑥𝑖−𝜇
𝑆𝐷
, where xi is a value of a single 
datapoint, µ the population mean and SD the population standard deviation) from a normal 
distribution, suitable for a large number of studied samples (>30) [147]. In essence, the z-score 
is a distance-measurement of a single datapoint in relation to a normal distribution’s standard 
deviation, determining the distance between its mean and single measurement. 
A Mann-Whitney U-test [147] can be fitted for non-Gaussian distribution data. It is typically 
combined with a Benjamini-Hochberg (or Bonferroni-Holm [63]) test to exclude false positive 
values, thus providing the FDR. These methods were applied in multiple studies to limit 
uncertainty in the results of lipids. Furthermore, Paepe et al. [27] and Gong et al. [60] used 
cross-validated ANOVA test (CV-ANOVA) to improve reliability of the identified analytes. 




with the Benjamini-Hochberg test [145] were used to discover the real positive results from 
analysed MS datasets.   
In the Benjamini-Hochberg method [145] p-values of two sample sets (between the control and 
the test groups) are inflated mathematically to reveal possible false positive results. Since 
affected and unaffected lipids represent two distinct normal distributions, false positive values 
can be ideally seen to differentiate a distribution from the normal when using a big sample 
number in the study. In the data analysis of lipid species, the original p-values are inflated and 
excluded by their significance desired for the p-values (e.g. p=0.1, 10% significance). The p-
values are then ranked from the smallest to the largest, after which the individual p-values are 
converted to a largest-to-smallest sequence. The largest p-value is kept, but the second largest 
p-value is determined as the smaller value of the two options. Therefore, either it is the same 
value preceding it, or it is the value calculated with a separate equation [145]. 
Lately, Tietz-Bogert et al. [31] calculated the FDR value in a lipido-metabolomic study by 
searching significant biomarkers of primary sclerosing cholangitis [31], which is a disorder of 
lipids in the bile duct of unknown origin. The concentrations of lipid species in control samples 
of healthy individual’s and the clinical samples of sick patient’s blood and bile were compared 
to find changes with a statistical significance of p=0.01 [31]. Simpler classical methods like 
ANOVA for multiple variables [2], [32], [46] were only occasionally used.  
Machine learning and software advancements for multi-ionic identification have allowed to 
evaluate MS spectra produced with UHPLC-MS in silico, which is only demonstrated in a few 
recent articles within our scope [3], [18], [21], [25], [33], [67]. Due to machine learning 
techniques and their discovered use in omics, automated lipidomic analyses, receiver operating 
characteristic curve/area under curve (ROC/AUC) cross-validation analyses [3], [60], [67], 
[76] random forest studies [18], [32], [59], [67], neural network applications [67], [96], in silico 





UHPLC-MS lipidomics is divided into isotope-labelled standard methods and fully 
standardless algorithm-based analyses. Furthermore, the separation and acquisition of highly 
abundant lipid classes (mmol/L) from mid- (µmol/L) and low-abundance (≤nmol/L) classes 
and their species is a challenge. [113] This is especially the case when (semi-)quantitative 
analysis is conducted for all quantifiable lipids in the sample, which can be the case for in-
depth studies on biological materials.  
When comparing matrix effects in pharmacokinetic analysis made with HPLC and supercritical 
fluid chromatography (SFC) coupled with ESI-MS/MS, Svan et al. [148] observed a higher 
amount of ion suppression in SFC than in HPLC due to more ion enhancement. Is this general 
notion also applicable to HPLC-MS in lipidomics? Further information may be obtained from 
matrix effects via post-column infusion [148] as demonstrated by Drotleff et al. [75] or 
observations from more laborious (though more informative) post-extraction process. [149] 
Both of these tools may be important for improving the understanding of lipidome analysis in 
the future, as sightings of such matrix effect analysis is rare in recent lipid papers. 
For practical reasons, a limitation of the comprehensive lipidome analysis is caused by the 
lipids without reasonable sensitivity. [9] Thus, the solution in that case is the Pareto principle, 
i.e. a limited number of biomolecules (lipid species) can be explained and measured using the 
main part of the studied biomass. [9] This is especially understandable in studies, where all the 
components are not relevant to the scientific question proposed. For example, metabolic lipid 
profiling with uncorrelated variation analysis (PLS-DA, OPLS-DA) in combination with 
metabolic knowledge highlight certain lipids from others to determine the most viable 
biomarkers. These biomarkers may form a conjoint array, which can already explain the 




The studies reviewed revealed a constant change, which affect retention time and peak focusing 
in a HPLC method: flow rate, gradient and oven temperature. Apart from an isocratic [43] and 
three-solvent eluents [10], [32], using aqueous - organic solvent gradients by increasing organic 
solvent percentage appeared in stepped (two [21], [40], [48] to three [25], [29], [38], [39] 
plateau steps or two [6], [69] to three [51] inclined steps), curved (exponential, [8], [37], [45], 
[67] logarithmic, [2], [19], [24], [41], [42], [50], [71] or s-curve [20], [27], [39], [49], [59], 
[63], [66]) and most popularly in linear [3], [9], [12], [13], [16], [17], [18], [22], [26], [28], 
[33], [34], [47], [52-54], [56], [67], [78] form. Modifications and combinations such as an 
inverted (i.e. increase in polar solvent percentage) linear [60], [79] or logarithmic [11] gradient, 
pyramidic [57], [77], pit-like [15], modified S-curve [5], [7], [45], [64] linear/isocratic [19], 
[23], exponential/linear [62], [68], [75], exponential/exponential [65], S-curve/exponential [64] 
and S-curve/isocratic [5] gradient were also used.  
In particular, it was observed that the lipid studies were done under various column heating 
temperatures, from room temperature to 65 ˚C. [65] Instrumentation for keeping the oven 
temperature stabile is very important in lipids analysis standardization. Furthermore, the 
research was done under various mobile phase temperatures, i.e. lipid analytes experienced 
significant temperature changes (up to 10-20 ˚C) from column inlet to outlet. [107], [150] In 
addition, as heat is propagated from the column walls to the centre, temperature gradients are 
evident. [107] Though this is partly considered by narrow bore packed columns and the pre-
equilibration of the analyses, the eluents flown from solvent units in room-temperature may 
cool down the column unevenly resulting in separation of lipids with low resolution.  
The choose of column properties in lipid analyses should be considered by sorbent chemistry 
[109], particle size, pore size [86], and particle technology [117]. The unanimously preferred 
column (i.d. 2.1 mm) is not necessarily optimal, since narrower columns are more prone to wall 




bigger columns (internal diameter larger, i.d.). Moreover, a bigger i.d. (3 mm) is argued to 
enhance column efficiency and allow higher flow rates. [107] However, this may be an 
insignificant issue compared to the current disparity in lipidome method standardization and 
validation. [97] 
Avanti Polar Lipids (https://avantilipids.com/tech-support/physical-properties/ionization-
constants) provides pKa-values of phospholipids to be closest to buffer pKa at 2.6 (PS 
phosphate group), 3 (PAs), 2.9-3.5 (PGs) and 5.5 (carboxyl group of PS) when compared to 
the pKa values of formic acid (3.74 [151]) and acetic acid (4.75 [151]). This means that when 
those organic acids are used PSs (and PAs/PGs at low pH) are never once charged ions. Further 
problems may arise for amines such as in sphingosine (pKa 9.1 [152]), PE (9.6 [153]) or PS 
(9.8 [153]) when ammonia (pKa 9.25 [151]) is used. Modifiers used as eluent additives may 
also lead to fluctuations of pH in non-buffered systems in on-line coupled HPLC-MS. [154] 
The phenomena are possible either in the eluent during electrochemical ionization due to 
charge-balancing redox reactions, and during droplet shrinkage, since it may cause structural 
perturbations and discrepancy in the ratios of ionization species. [154] 
In lipidome analytics, interdisciplinary analyses on multifunctional and computational methods 
will be crucial to effective and improved data processing. Furthermore, it is important to use 
the most practical parameters such as precursors, fragments, and CCS values in evaluation of 
data to get fast identification and determination of lipids. Multifunctional methods used are 
statistic and chemometric analyses, whereas computational methods include algorithms, data-
processing interfaces, specific software, and machine learning strategies. Both method 
categories were attempted to be refined with tailored software platforms for necessary data pre-





Concerning common terminology, Aristizabal et al. [155] suggest names depending on the 
acquired structural information: brutto (e.g. PC 36:1), medio (e.g. PC(18:0/18:1), sn-position 
not known), genio (e.g. PC(18:0/18:1), sn-position known) and infinio (e.g. PC(18:0/18:1-9Z), 
sn-position not known). The same research group identified two distinct trends in lipidomics, 
which are the global analysis of lipids (coined macrolipidomics) and the specialized analyses 
for low-abundant lipids (microlipidomics). 
Finally, the recognition correlation of HCA analyses is derived from information often 
visualized in the Heatmaps. Since HCA sorts out (i.e. clusters) groups of similar analyte species 
with each other, similar tools can potentially be developed by means of identifying and 
distinguishing matrices from each other.  
As the scope of this review focuses mainly on UHPLC applications, it may limit some aspects 
of progress in HPLC-MS lipidomics as a whole. However, this was deemed necessary as 
publications on lipidomics have drastically increased. [156], [157] In our opinion -as may be 
representative for lipid studies in general- the most neglected topic mainly left out in the dataset 
was nutritional lipidomics [133] (mainly personalized nutrition [158] and nutritional 
intervention [159] studies). This is in tune with the main tendency of lipidomics towards life-
sciences and bioanalytical questions concerning physiology and pathology. Furthermore, 
UHPLC-IMS-MSn studies were rarer than might be expected from current trends in HPLC-
IMS-MSn lipidomics. Our dataset between the years 2017-2019 (topics discussed elsewhere 
[101]) included research on lipid method development, physiological profiling and metabolic 
changes via multicomponent analysis including drug development and biomarker studies. 
Sample matrices included plants, microbiota, mammals, fish and human patients. [101] 
As UHPLC instruments are less frequent in the total scheme of lipidomics compared to the 
commonly used HPLC instruments, limitations concerning this review’s scope on lipidome 




by Castro-Gómez et al. [15] though some studies use a HPLC-MS ternary gradient separation 
in the fashion of Graeve et al. [160] ; acetone/ethyl acetate (v/v 2:1) and alkane:ethyl acetate 
(alkane: e.g. isooctane or n-heptane, v/v 99.8:0.2)  is applied. [161] The lipidome community 
has also gone out of its way to develop a comprehensive and high-throughput method for lipid 
analysis, which puts emphasis on simple and quick sample preparation, high 
resolution/sensitivity MSn analysis and data handling via extensively automated data 
processing. Consequently, a derivatization step for UHPLC-MS was used only once in our 
dataset [8] where TMSD methylation was applied for separate acidic lipid analysis; neutral and 
basic lipids were directly analysed after sample preparation. [8] Though derivatization may be 
necessary for very low-abundance lipids or to increase lipid class specificity, another reason 
for the reduction of sample preparation steps is the minimization of experimental errors. [137] 
A particularly important outlier in lipidome applications was the research on double bond 
position elucidation; for the absolute determination of double bond positions, other options 
than multiple collision MSn-experiments or spectral library matching have been developed.  
7 Conclusions 
Current challenges in lipidomics are closely related to the lack of uniform methods across the 
field. Compared with the lipid research generally made with RP-HPLC-MS, UHPLC-MS 
needs more focus on the chromatographic method parameters, such as stationary (e.g. column 
choice, oven temperature) and mobile phase properties (flow rate, pH, solvents, gradients, 
eluent modifiers).  
Normalization with representative or single internal standards has been widely adopted in the 
field. Since computational methods alongside chemometric and statistical methods have 
increased in both importance and usage in HPLC-MS technology for cross-validation and data-
analysis, lipidomics needs interdisciplinary studies to reach full potential with big and complex 




parts: Pre-processing, identification/quantitation, chemometric, and statistical analyses. A 
substantial amount of specific processing tools are provided, i.e. commercial and open-source 
ones, including self-made algorithms. Since ever, more lipid libraries have emerged as well for 
untargeted, relatively targeted and in silico methods. Currently, chemometric analyses appear 
to be popular in lipidomics, i.e. for developing methods, profiling lipids in samples, and 
evaluating metabolic relationships between lipid species. For accurate identification, ion 
mobility mass spectrometry has been applied with liquid chromatography, alongside 
chromatographic separation modes with mass-spectrometric ionization, or/and MSn systems. 
When chemometric methods shed light to the inter- and intra-analyte properties of typically 
biological medium, statistical analyses were used for data-validation (e.g. significance testing 
and filtering out of false positives) and detection of abonormal changes (e.g. metabolic 
profiling of diseases).  
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[158] Ibáñez, C., Mouhid, L., Reglero, G., & Ramírez de Molina, A. (2017). Lipidomics 
insights in health and nutritional intervention studies. Journal of agricultural and food 
chemistry, 65(36), 7827-7842. 
[159] de Castro, M. L., & Quiles-Zafra, R. (2020). Lipidomics: an omics discipline with a key 
role in nutrition. Talanta 219, article 121197. 
[160] Graeve, M., & Janssen, D. (2009). Improved separation and quantification of neutral 
and polar lipid classes by HPLC–ELSD using a monolithic silica phase: application to 
exceptional marine lipids. Journal of Chromatography B 877(20-21), 1815-1819. 
[161] Imbert, L., Gaudin, M., Libong, D., Touboul, D., Abreu, S., Loiseau, P. M., ... & 




ionization and atmospheric pressure photoionization for a lipidomic analysis of Leishmania 








Supplementary Table S1. Experimental conditions for the solid and mobile phase in chromatography 
Precolumn Column Polar Solvent (v/v ratios) Organic Solvent (v/v ratios) Solvent C Additives Year Citation 
Yes T3 C18 1:1 MeOH:H2O (pH 7.5) (PG;PS) 6:4 MeOH:ACN (GP;PS) 
 
AmFo, FoA 2017 [15] 
 
C18 HSS 19:19:2 ACN:MeOH:H2O IPA 
 
AmFo, FoA 2017 [8] 
 
C18 HSS T3 3:4:3 ACN:acetone:IPA (DG;TG) 3:7 ACN:IPA (DG;TG) 
 
AmOH 2017 [15] 
 
C18 BEH 40:60 ACN:H2O 90:10 IPA:ACN 
 
AmAc, AcA 2017 [19] 
 
N/A 40:60 ACN:H2O 90:10 IPA:ACN 
 
AmAc 2017 [18] 
 
C18 50:50 ACN:H2O 95:5 IPA:ACN 
 
AmFo, FoA 2017 [20] 
 
C18 CSH H2O  50:50 IPA:ACN 
 
AmFo, FoA 2017 [11] 
 
C18 60:40  MeOH/H2O 60:40 MeOH:IPA 
 
AmAc, AcA 2017 [7] 
 
C18 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmAc 2017 [22] 
 
C18 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2017 [21] 
 
C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
- 2017 [4] 
 
C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmAc, FoA 2017 [6] 
 
C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmAc 2017 [22] 
 
C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2017 [14] 
 
C18 HSS 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo 2017 [3] 
 
C18 BEH 90:10 ACN:H2O 90:80:1 IPA:ACN:H2O 
 
AmFo, FoA 2017 [17] 
 
C18 BEH* 90:10 H2O:ACN 20:20:60 MeOH:ACN:IPA 
 
AmFo, FoA 2017 [24]* 
 
C18 HSS T3 90:10 IPA:ACN 30:70 H2O:ACN 
 
AmFo 2017 [12] 
 
HILIC, BEH H2O 96:4 ACN:H2O 
 
AmAc 2017 [16] 
 
C8 BEH H2O 2:5 IPA:ACN 
 
AmFo, FoA 2017 [9] 
 
C18 BEH H2O 50:50 IPA:ACN 
 
- 2017 [19] 
 
C18** H2O 60:36:4 IPA:ACN:H2O 
 
AmFo 2017 [23]** 
 
C8 H2O 70:30 ACN:IPA 
 
AmAc, FoA 2017 [2] 
 
C18 BEH H2O ACN 90:10 IPA:ACN FoA 2017 [10]  
C18 HSS T3 H2O ACN 
 
FoA 2017 [13] 
 
C18 BEH H2O MeOH 
 
AmAc 2017 [5] 
*nano-LC, **APCI instead of ESI, ***narrow-bore UHPLC  




Precolumn Column Polar Solvent (v/v ratios) Organic Solvent (v/v ratios) Solvent C Additives Year Citation 
 C18 CSH 40:60 ACN:H2O 90:10 IPA:ACN  AmFo, FoA 2018 [35]  
C18 45:55 ACN:H2O 
  
AcA 2018 [43]  
C18 BEH 60:40 ACN:H2O 81:10:9 IPA:ACN:H2O 
 
AmFo, FoA 2018 [40]  
C18 CSH 60:40 ACN:H2O 90:10 ACN:IPA 
 
AmFo, FoA 2018 [39]  
C18 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo 2018 [33]  
C18 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmAc 2018 [38] 
Yes C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2018 [25]  
C18 HSS 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo 2018 [26] 
Yes C18* 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2018 [45]* 
Yes C18*** 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2018 [45]***  
C8 BEH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmAc 2018 [30]  
C8 BEH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmAc 2018 [30]  
C18 BEH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo 2018 [28]  
C18 BEH 60:40 ACN:H2O 90:8:2 IPA:ACN:H2O 
 
AmFo, FoA 2018 [46] 
Yes C18 BEH* 90:10 H2O:ACN 20:20:60 MeOH:ACN:IPA 
 
AmFo, FoA 2018 [41]* 
Yes C18 BEH* 90:10 H2O:ACN 20:20:60 MeOH:ACN:IPA 
 
AmFo, FoA 2018 [42]*  
C18 SB H2O 90:10 ACN:H2O 
 
AmAc, AcA 2018 [29]  
C18** H2O ACN 
 
FoA 2018 [44]**  
C18 BEH H2O ACN 90:10 IPA:ACN FoA 2018 [32]  
C18 BEH H2O ACN 
 
AcA 2018 [37]  
C18 HSS H2O ACN 
 
FoA 2018 [27]  
Amide H2O MeOH 
 
AmHCO3 2018 [31]  
Amide H2O MeOH 
 
AmFo 2018 [31]  
C18 BEH H2O MeOH 
 
PFPA, FoA 2018 [31]  
C18 BEH H2O MeOH 
 
PFPA, FoA 2018 [31]  
C18 CSH H2O MeOH 
 
FoA 2018 [34]  
C18 HSS H2O MeOH 
 
FoA 2018 [39] 
*nano-LC, **APCI instead of ESI, ***narrow-bore UHPLC  




Precolumn Column Polar Solvent  (v/v ratios) Organic Solvent (v/v ratios) Solvent C Additives Year Citation 
  C18 BEH* 10:90 H2O:ACN 20:20:60 MeOH:ACN:IPA   AmFo, NH3 2019 [71] 
  C18 CSH 40:60 ACN:H2O 90:10 IPA:ACN   AmFo, FoA 2019 [77] 
 
C18 50:50 ACN:H2O 20:80 IPA:MeOH 
 
AmAc 2019 [52] 
  C18 50:50 H2O:ACN 5:95 ACN:IPA   AmFo, FoA 2019 [50] 
 
C18 50:50 H2O:ACN 5:95 ACN:IPA 
 
AmFo, FoA 2019 [57] 
Yes C18 CSH 60:40 ACN:H2O 90:10 ACN:H2O   AmFo, FoA 2019 [55] 
  C18 HSS T3 60:40 ACN:H2O 90:10 ACN:IPA   AmFo, FoA 2019 [60] 
 
C18 CSH 60:40 ACN:H2O 90:10 ACN:IPA 
 
AmFo, FoA 2019 [60] 
Yes C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2019 [66] 
 
C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2019 [74] 
 
C8 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmAc 2019 [56] 
 
C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo, FoA 2019 [65] 
 
C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN 
 
AmFo 2019 [79] 
  C18 60:40 ACN:H2O 90:10 IPA:ACN   AmFo 2019 [78] 
  C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN   AmFo, FoA 2019 [69] 
 C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN  AmFo 2019 [62] 
 C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN  AmAc 2020 [64] 
  C18 CSH 60:40 ACN:H2O 90:10 IPA:ACN   AmAc 2020 [64] 
Yes C18 BEH 60:40 ACN:H2O 90:8:2 IPA:ACN:H2O   AmFo, FoA 2019 [63] 
Yes C18 CSH 60:40 ACN:H2O 90:9:1 IPA:ACN:H2O   AmFo, FoA 2019 [75] 
Yes C18 CSH 60:40 ACN:H2O 90:9:1 IPA:ACN:H2O   AmFo, FoA 2019 [76] 
 C18 CSH 60:40 H2O:ACN 90:10 IPA:ACN  AmFo, FoA 2019 [58] 
 HILIC 70:30 ACN:H2O 90:10 ACN:acetone  AmFo, FoA 2019 [47] 
  HILIC** 70:30 ACN:H2O 90:10 ACN:acetone   AmFo, FoA 2019 [47]** 
 C18 BEH ACN:H2O IPA:ACN  AmFo 2019 [67] 
  C18 CSH H2O 16:3 ACN:MeOH   AcA 2019 [68] 
*nano-LC, **APCI instead of ESI, ***narrow-bore UHPLC  




Precolumn Column Polar Solvent  (v/v ratios) Organic Solvent (v/v ratios) Solvent C Additives Year Citation 
Yes C8 H2O 55:40:5 ACN:IPA:H2O  AmAc 2019 [68] 
  C18 H2O 75:25 IPA:ACN   AmFo 2019 [59] 
 C18 H2O 75:25 IPA:ACN  AmAc 2019 [59] 
  C18 BEH H2O ACN   FoA 2019 [67] 
  F5 H2O IPA   AmFo, FoA 2019 [51] 
  C18 H2O MeOH   AmAc, FoA 2019 [53] 
 C18 H2O MeOH  AmAc, FoA 2019 [53] 
Yes Phenyl H2O MeOH   AmAc 2019 [49] 
  C8 BEH H2O MeOH   AmFo, FoA 2019 [48] 
 C18 BEH MeOH 2:5 ACN:IPA  AmAc, FoA 2019 [54] 
  C18 HSS N/A N/A   N/A 2019 [61] 
*nano-LC, **APCI instead of ESI, ***narrow-bore UHPLC  







Table 1. Instrumental approaches and MS or MS/MS chromatographic methods. Ionization 
mode was done either in positive (pos), negative (neg) or polarity switch (Switch) ion mode. 
Approach Column ESI mode MS/MS Tandem mode Year Citation 
UHPLC-ESI-Orbitrap   Pos/Neg No - 2017  [2] 
UHPLC-ESI-QOrbitrap Silica Pos/Neg No - 2017  [3] 
UHPLC-ESI-QTOF CSH Pos No - 2017  [4] 
UHPLC-HESI-Orbitrap BEH Switch  No - 2017  [5] 
UHPLC-Zspray-IMS-QTOF CSH Pos/Neg No - 2017  [6] 
UHPLC-ESI-QqQ-MS/MS   
Pos (SPs)/Neg 
(SM) 
Yes MRM 2017  [7] 
UHPLC-ESI-QqQ-MS/MS Silica Pos/Neg Yes MRM 2017  [8] 
UHPLC-ESI-QOrbitrap-MS/MS C8 BEH Pos/Neg Yes MSE 2017  [9] 
UHPLC-ESI-QTOF-MS/MS BEH Pos/Neg Yes MSE 2017  [10] 
UHPLC-ESI-QTOF-MS/MS CSH Pos/Neg Yes MSE 2017  [11] 
UHPLC-ESI-QTOF-MS/MS HSS Pos/Neg Yes MSE 2017  [12] 
UHPLC-ESI-QTOF-MS/MS   Pos Yes MSE 2017  [13] 
UHPLC-ESI-QTOF-MSMS CSH Pos/Neg Yes MSE 2017  [14] 
UHPLC-ESI-QTOF-MS/MS HSS Pos/Neg Yes MSE, PRM 2017  [15] 
UHPLC-ESI-IMS-QTOF-MS/MS   Pos Yes N/A 2017  [16] 
UHPLC-ESI-QOrbitrap-MS/MS BEH Switch  Yes N/A 2017  [17] 
UHPLC-ESI-QOrbitrap-MS/MS   Pos/Neg Yes N/A 2017  [18] 
UHPLC-HESI-QOrbitrap-MS/MS BEH Pos/Neg Yes PIS 2017  [19] 
UHPLC-HESI-QOrbitrap-MS/MS   Pos/Neg Yes PIS 2017  [20] 
UHPLC-ESI-QTOF-MS/MS   Pos/Neg Yes PIS? 2017  [21] 
UHPLC-HESI-QOrbitrap-MS/MS CSH Pos/Neg Yes product ion scan 2017  [22] 
UHPLC-ESI(/APCI)-QqQ-MS/MS ** Switch Yes SIM 2017  [23] 
AF4, nUHPLC-ESI-QqQ-MS/MS * Pos/Neg Yes SRM, PIS 2017  [24] 
UHPLC-ESI-IMS-QTOF CSH Pos No - 2018  [25] 
UHPLC-ESI-QOrbitrap Silica Pos/Neg No - 2018  [26] 
UHPLC-HESI-QOrbitrap HSS Switch No - 2018  [27] 
UHPLC-ESI-QTOF BEH Pos No? - 2018  [28] 
UHPLC-ESI-Qtrap-MS/MS SB Neg Yes 
enh. product ion 
scan, MRM 
2018  [29] 





Pos/Neg Yes MRM 2018  [31] 
UHPLC-ESI-QTOF-MS/MS BEH Pos/Neg Yes MSE 2018  [32] 
Enh.: enhanced, PIS: precursor ion scan, *nano-LC, **APCI instead of ESI, ***narrow-bore LC  
BEH: ethylene bridged hybrid, CSH: charged surface hybrid, HSS: high strength silica,  
SB: stable bond packing 
 
Approach Column ESI mode MS/MS Tandem mode Year Citation 
UHPLC-ESI-QTOF-MS/MS   Pos/Neg Yes MSE 2018  [33] 
UHPLC-ESI-QOrbitrap-MS/MS CSH Pos/Neg Yes MSE, MRM 2018  [34] 
UHPLC-HESI-QOrbitrap   Pos/Neg Yes N/A 2018  [35] 
UHPLC-ESI-QTOF-MS/MS   Pos/Neg Yes PIS 2018  [36] 
UHPLC-QTOF-MS/MS BEH Pos/Neg Yes PIS 2018  [37] 




Pos/Neg Yes Targeted 2018  [39] 
UHPLC-ESI-QTOF-MS/MS BEH Pos/Neg Yes product ion scan 2018  [40] 
AF4, nUHPLC-ESI-QqQ-MS/MS * Switch Yes SRM 2018  [41] 
AF4, nUHPLC-ESI-QqQ-MS/MS * Pos/Neg Yes SRM 2018  [42] 
UHPLC-ESI-QQQ   Neg Yes SRM 2018  [43] 
UHPLC-ESI(neg: APCI)-QTOF-
MS/MS 
** Pos/Neg Yes SWATH, PRM 2018  [44] 
nUHPLC-NSI-QTOF-MS/MS */*** Pos/Neg Yes Top10 ddMS2, PRM 2018  [45] 
UHPLC-HESI-QOrbitrap-MS/MS BEH Pos/Neg Yes top10-ddMS2 2018  [46] 
UHPLC-APCI-QLIT-MS HILIC** Pos No - 2019  [47] 
UHPLC-ESI-TOF C8 BEH Pos No - 2019  [48] 
UHPLC-HESI-QOrbitrap Phenyl Switch No - 2019  [49] 
UHPLC-ESI-Orbitrap-MS/MS   Pos/Neg Yes autoMS 2019  [50] 
UHPLC-HESI-QOrbitrap-MS/MS F5 Pos/Neg Yes autoMS 2019 [51] 
UHPLC-ESI-Qtrap-MS/MS   Pos/Neg Yes MRM 2019  [52] 
UHPLC-ESI-QTOF-MS/MS   Pos/Neg Yes 
MRM (GPs), 
product ion scan 
(FAs) 
2019  [53] 
UHPLC-ESI-QTOF-MS/MS BEH Pos Yes MRM, PIS 2019  [54] 
UHPLC-ESI-QOrbitrap-MS/MS CSH Pos/Neg Yes MSE 2019  [55] 
UHPLC-ESI-QOrbitrap-MS/MS C8 Pos/Neg Yes MSE 2019  [56] 
UHPLC-ESI-QOrbitrap-MS/MS   Pos/Neg Yes MSE 2019  [57] 
UHPLC-ESI-QOrbitrap-MS/MS CSH Pos/Neg Yes MSE 2019  [58] 
UHPLC-ESI-QTOF-MS/MS   Pos/Neg Yes MSE 2019  [59] 
UHPLC-ESI-QTOF-MS/MS   Pos/Neg Yes MSE 2019  [60] 
UHPLC-ESI-QTOF-MS/MS HSS Pos Yes MSE 2019 [61] 
UHPLC-ESI-QOrbitrap-MS/MS CSH Pos/Neg Yes Untargeted 2019 [62] 
UHPLC-ESI-QOrbitrap-MS/MS BEH Pos/Neg Yes N/A 2019  [63] 
UHPLC-ESI-QOrbitrap-MS/MS CSH** Pos/Neg Yes N/A 2020 [64] 
UHPLC-ESI-QOrbitrap-MS/MS CSH Pos/Neg Yes PIS 2019 [65] 
Enh.: enhanced, PIS: precursor ion scan, *nano-LC, **APCI instead of ESI, ***narrow-bore LC  
BEH: ethylene bridged hybrid, CSH: charged surface hybrid, HSS: high strength silica,  
SB: stable bond packing 
 
Approach Column ESI mode MS/MS Tandem mode Year Citation 




Pos Yes Targeted 2019  [60] 
UHPLC-HESI-QOrbitrap-MS/MS HILIC** Neg Yes Targeted 2019  [47] 
UHPLC-ESI-QTOF-MS/MS BEH** Pos/Neg Yes 
Product ion scan, 
NLS 
2019 [67] 
UHPLC-ESI-IMS-QTOF-MS/MS CSH Neg Yes 
Product ion scan, 
PIS 
2019  [68] 
UHPLC-ESI-QTOF-MS/MS CSH Pos/Neg Yes SONAR 2019 [69] 
nUHPLC-ESI-QTOF-MS/MS   Pos/Neg Yes SRM 2019  [70] 
nUHPLC-NSI-QTOF-MS/MS * Pos/Neg Yes SRM 2019  [71] 
AF4, nUHPLC-ESI-QOrbitrap-MS/MS   Pos/Neg Yes SRM, PIS 2019  [72] 
UHPLC-ESI-QTOF-MS/MS   Pos/Neg Yes SWATH 2019  [73] 
UHPLC-ESI-QTOF-MS/MS CSH Pos/Neg Yes SWATH 2019  [74] 
UHPLC-ESI-QTOF-MS/MS CSH Pos/Neg Yes SWATH 2019  [75] 
UHPLC-ESI-QTOF-MS/MS CSH Pos/Neg Yes SWATH 2019  [76] 
UHPLC-HESI-QOrbitrap-MS/MS CSH Pos/Neg Yes Top10-ddMS2 2019  [77] 
UHPLC-ESI-QTOF-MS/MS   Pos/Neg Yes  N/A 2019 [78] 
UHPLC-HESI-QOrbitrap-MS/MS CSH Pos/Neg Yes Targeted 2019 [79] 
Enh.: enhanced, PIS: precursor ion scan, *nano-LC, **APCI instead of ESI, ***narrow-bore LC  
BEH: ethylene bridged hybrid, CSH: charged surface hybrid, HSS: high strength silica,  
SB: stable bond packing 
  
Table 2. New analytic method developments and application enhancements in lipidomics  
Year Citation Subtheme 
2017  [21] Improvement to in-silico fragmentation prediction 
2017  [9] Ultrahigh performance chromatography lipidomics 
2017  [14] Super absorbent polymer extraction chip testing 
2017  [95] Single-cell resolution, PDMS microfluid droplet chip Raman method 
2017  [96] LipidMatch comparison to other software 
2017  [23] Method development, low resolution MS identification 
2017  [19] in vitro computational data analysis method, excessive adipocyte lipolysis 
2017  [16] Comparison of LC/MS, SCF/MS and DIMS, kidney cancer patient analysis 
2017  [22] Bee pollen analysis, method validation 
2017  [20] Lipid extraction comparison with pancreatic cancer cell line 
2017  [17] Data processing improvements, nonalcoholic fatty liver disease analysis 
2018  [25] Machine learning algorithms for CCS values 
2018  [45] Reproducible nano-LC NSI method 
2018  [27] Multi-matrix platform validation 
2018  [46] Optimization of established extraction techniques 
2018  [30] Multimatrix method development, a mixture of untargeted/targeted  
2019  [66] Extraction comparison ("IPA-75", "IPA-90" vs “Bligh & Dyer”), MS-DIAL, 
SWATH 
2019  [68] Oxylipin, eicosanoid and FA identification method with IMS-MS/MS (DIA),  
2019  [76] Guide for choosing a suitable strategy for an ISTD-based untargeted 
approach 
2019 [51] Method for hepatotoxicity evaluation 
2019 [69] DIA method with rapid "SONAR" sequential ion feeding scan,  
sitaxentan (antihypertension drug) effects in animals 
 
Table 3. Mass-to-charge values for several lipid classes found during research. Ch: cholesterol and its derivatives, Hex: SPs hexosyl-derivatives 
Citation Table FA FFA GL GP LPL PL Ox Sulfo-
GP 
SP Hex ST Ch SL PK PR adduct m/z CE more 
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Citation Table FA FFA GL GP LPL PL Ox Sulfo-
GP 
SP Hex ST Ch SL PK PR adduct m/z CE more 
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 [42] S3 
  
x x x X 
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 [41] S1, S2 
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List for possible acyl chains (S3) 
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Abundances in 5 cancer types 
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Adduct list, UHPLC/SFC/DIMS & tissue 
comparison, Des-lipids 
 [60] S1 
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PE(16:0/18:1)+H m/z fragments  
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x x x 
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Adduct list, Software comparison 
 [34] S1, S2 
  
x x x 




   
x x x MRM validation, methylated species 
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x x x nUHPLC, adduct list 
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Citation Table FA FFA GL GP LPL PL Ox Sulfo-
GP 
SP Hex ST Ch SL PK PR adduct m/z CE more 
[69] T1     x x         x             x x 
 
  
 [59] T2     x x             x     x   x x 
 
Plant flavonoids included 
[2] S1     x x                 x x   x 
  
Plant flavonoids included 
[125] S1, 
S2, S3 
   x x                 x   x x x 
 
archaeal isoprene-based and ether-linked 
lipid list (incl. fragment info) 
 [18] S3     x x                       x x 
 
  
 [50] T2, T5       x x       x             x x 
 
  




csv files (S2) 





[61] T1       x                       x x 
 
PC only 
 [29] S1             x                 
 
x x Oxylipins 
 [55] T2, S1                 x     x       x x 
 
SM and cholesterol 
 [40] S2                 x             x x 
 
protonated species only 
 [27] S1                     x         x x 
 
Metabolomic study 
 [44] A.144, 
A.155 
                   x         
   
SWATH 
 [54] S1                       x        
   




Table 4. Databases used for lipid identification 
Database Content Focus Used in Citation 
in-house Compound lists Lipids  [30], [32], [36], [51], [54], [68], [78] 
ChemSpider Structures, Library Comprehensive  [13], [127] 
Foodb Library Food constituents  [59] 
HMDB Various Metabolites  [4], [12], [19], [32], [34], [39], [40], [59], [60], [63], 
[127] 
KEGG Pathway maps Genes  [33], [34], [60], [79] 
LipidBlast Spectra Lipids  [6], [21], [25], [35], [76] 
LIPID MAPS Library Lipids  [4], [6], [9], [12], [16], [19], [26], [34], [39], [40], [54], 
[65], [69], [127] 
MassBank Mass spectra Comprehensive  [21] 
MetLin MS/MS Metabolites  [34], [39], [40], [63] 
NIST 11 Library Comprehensive  [60] 
Nist 14 Library Comprehensive  [25] 
PubChem Library Comprehensive  [13], [125] 
ChEBI* Library Metabolites  [125] 
Lipidbank Compound lists Lipids  [125] 
Reactome Library Pathways  [26] 
Home-made Various Various  [30], [32], [36], [54], [68] 
Table 5. Coding languages, possible packages and specific softwares for analysis of lipids 
typically under the m/z value of 1500. 
Availability Program A/IQ/S/V More Used in Citation 
MathWorks Matlab n/y/y/y Coding language  [49] 
DoubleClick Origin n/n/y/y Coding language  [44], [75], [76] 
Open-source Python n/y/y/y Coding language  [25] 
Open-source R n/y/y/y Coding language, 
statistics 
 [2], [3], [6], [7], [10], [18], [21], [32], [33], [36], 
[37], [39], [40], [46], [47], [55], [65], [67], [68], 
[74], [76], [78] 
    -Out of which CAMERA n/y/n/n Isotope screening  [6], [21], [37], [55] 
    -Out of which MeV n/y/y/y DB search, 
visualization 
 [3], [30] 
    -Out of which XCMS n/y/n/n Feature detection  [7], [10], [19], [32], [33], [36], [37], [39], [46], 
[47], [55], [61], [65], [76], [78] 
IBM SPSS n/y/y/y Coding language, 
statistics 
 [7], [26], [33], [42], [44], [50], [53], [54], [55], 
[57], [60], [61], [64], [72], [75], [79]  
Agilent Masshunter series y/y/n/n Multiple tools  [7], [25], [34], [40], [54], [68] 
GraphPad GraphPad Prism n/n/y/y Statistics, Data 
visualization 
 [56], [57] 
KBSI iLipid n/y/n/n In-house  [14] 
Molecular Discovery Lipostar n/y/y/y Identification 
only 
 [65] 
N/A LiPilot n/y/n/n In-house  [24], [42] 
Open-source CEU Mass Mediator n/y/n/n Adduct/s and RT, 
website 
 [32], [63] 
Open-source Cytoscape n/n/n/y Visualization  [79] 
Open-source MetaboAnalyst n/y/y/y Multipurpose, 
website 
 [10], [11], [17], [27], [32], [34], [37], [40], [46], 
[48], [59], [60], [61], [63], [65], [77], [79] 
Open-source Greazy n/y/y/y Chemometrics 
included 
 [96] 
Open-source KniMet n/n/y/n Visualization  [68] 
Open-source Lipid Data Analyzer n/y/y/y Standardization, 
statistics 
 [9] 
Open-source LipidFrag n/y/n/n In silico  [21] 
Open-source LipidMatch n/y/n/n In silico, 
fragmentation 
DBs 
 [3], [17], [63] 
A/IQ/S/V: Acquisition/Identification & Quantitation/Statistical analysis/data Visualization 
*According to Waters’ website, MassLynx is discontinued and replaced with Progenesis QI 
DB: database, KBSI: Korea Basic Science Institute 
 
 
Availability Program A/IQ/S/V More Used in Citation 
Open-source MassTRIX n/y/n/y KEGG/API 
pathway analysis 
 [21] 
Open-source MultiExperiment Viewer n/n/n/y Chemometric 
visualization 
 [56] 
Open-source MZmine n/y/n/n MS DB search  [63], [123] 
Open-source Skyline n/y/n/n MS/MS DB 
search 
 [7], [34], [45], [69] 
Premier Biosoft SimLipid n/y/n/n In silico structure 
MS/MS 
 [10], [32], [61] 
Riken Prime MS-DIAL n/y/n/n SWATH  [35], [58], [73], [75-77]  
Sartorius SIMCA n/n/y/y Statistics and 
visualization 
 [5], [26], [33], [35], [36], [68], [79], [124] 
Sartorius SIMCA-P n/n/y/y Same as SIMCA  [7], [19], [30], [37], [52], [54], [56], [62] 
Sartorius EZinfo n/n/n/y Chemometrics  [4], [13], [34], [60], [69] 
SAS JMP n/n/y/y    [56] 
SCIEX Analyst TF y/n/n/n    [44], [33], [36] 
SCIEX LipidView n/y/n/n Fragment DB 
search 
 [16], [38], [43] 
SCIEX MultiQuant n/y/n/n Quantitation tool  [75], [76] 
SCIEX PeakView n/y/n/n Peak comparison 
& analysis 
 [76] 
SCIEX MarkerView n/n/y/y    [38], [73], [76] 
Thermo Xcalibur y/n/n/n    [2], [3], [5], [18], [26], [45], [46], [50], [58], [60], 
[62], [65], [124] 
Thermo Compound Discoverer n/y/y/y Pathway analysis  [46] 
Thermo LipidSearch n/y/n/n Relative 
quantification 
 [22], [26], [30], [35], [46], [50], [57], [62], [65], 
[79], [124] 




Thermo SIEVE n/n/y/n Biomarker 
discovery 
 [19] 
Thermo Chromeleon y/n/n/n    [65] 
Waters MassLynx MS y/y/n/n    [7], [13-15], [28], [34], [60], [61], [69] 
Waters MarkerLynx* n/n/n/y Chemometrics  [4], [6], [16], [34], [43], [67] 
Waters, Nonlinear 
Dynamics 




A/IQ/S/V: Acquisition/Identification & Quantitation/Statistical analysis/data Visualization 
*According to Waters’ website, MassLynx is discontinued and replaced with Progenesis QI 
DB: database, KBSI: Korea Basic Science Institute 
Figures: 
 
Figure 1. Simple triglyceride (TG) structure and shorthand notation. The stereospecific 
numbering (sn) of fatty acids on a glycerol-molecule are named sn1 (upper carbon of the 
glycerol body, if k>n), sn2 (middle carbon of the glycerol body) and sn3 (lower carbon of the 
glycerol body, if k>n) respectively, when the analyte can be stereoisomerically determined 
(i.e. on the stereo-molecular species level). If individual chain lengths (and their positions) 
cannot be determined, the number of the carbon atoms and double bonds are expressed as 
separate sums. 
Figure 2. (A) Glycero- and glycerophospholipid structure variations according to sub-class 
and (B) regular and plasmalogen structures (O- for plasmanyl and P- for plasmenyl, older 
notation e and p). The characteristic molecules of lipid classes are typically esterified to the 
sn3 position. Structures derived from ref. [93] 
Figure 3.  Typical sphingolipid structures. R1 is an amine that usually has a fatty acid linked 
to it with an amide bond. R2 on the other hand is either a free hydroxyl group as in ceramides 
but occupied with a characteristic phosporylated molecule in SMs. Some structures also  
Structures derived from ref. [93] 
Figure 4. ‘(a)’ Nonpolar and ‘(b)’ polar lipid subclass separation techniques. Reprinted from ref 
[85], DOI: 0958-1669/© 2016 S. Tumanov and JJ Kamphorst. Published by Elsevier Ltd, an 
open access article under the CC BY license. 
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